NCT Number,Study Title,Study URL,Study Results,Conditions,Interventions,Sex,Age,Phases,Locations
NCT01206374,Questionnaire and Laboratory Data on Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT01206374,NO,Vitiligo Vulgaris,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Department of Dermatology, Beth Israel Medical Center, New York, New York, 10003, United States|Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, New York, 10025, United States"
NCT01401374,Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo,https://clinicaltrials.gov/study/NCT01401374,NO,Vitiligo Vulgaris,,ALL,"CHILD, ADULT, OLDER_ADULT",,"St. Luke's-Roosevelt Hospital Center, New york, New York, 10025, United States"
NCT00907062,Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents,https://clinicaltrials.gov/study/NCT00907062,NO,Vitiligo Vulgaris,DIETARY_SUPPLEMENT: Ginkgo biloba,ALL,"CHILD, ADULT",PHASE1,"Noumena Naturopathic Health Clinic, Mississauga, Ontario, L5H 1H2, Canada"
NCT00372307,Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris,https://clinicaltrials.gov/study/NCT00372307,NO,Vitiligo Vulgaris,DRUG: Application of pimecrolimus,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"University Hospital Ghent, Ghent, 9000, Belgium"
NCT03234673,"The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo",https://clinicaltrials.gov/study/NCT03234673,NO,Vitiligo Vulgaris,DRUG: Tacrolimus ointment|DRUG: calcipotriol ointment|DRUG: NB-UVB,ALL,"CHILD, ADULT",PHASE1,
NCT05607316,Evaluating the Efficacy and Safety of Metformin in Vitiligo,https://clinicaltrials.gov/study/NCT05607316,NO,Vitiligo,DRUG: Metformin Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE2,"UMass Chan Medical School, Worcester, Massachusetts, 01605, United States"
NCT05869942,Histochemical Study of Vitiligo in Sohag University Hospital Patients,https://clinicaltrials.gov/study/NCT05869942,NO,Vitiligo,DIAGNOSTIC_TEST: Light microscopic studies|DIAGNOSTIC_TEST: Immunohistochemical studies,ALL,ADULT,NA,"Sohag University Hospital, Sohag, Egypt"
NCT05971381,Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells,https://clinicaltrials.gov/study/NCT05971381,NO,Vitiligo,DEVICE: RECELL® Autologous Cell Harvesting Device,ALL,"ADULT, OLDER_ADULT",NA,"Affiliated Dermatology, Scottsdale, Arizona, 85225, United States|University of California, Irvine, Irvine, California, 92697, United States|West Dermatology Research Center, San Diego, California, 92121, United States|Sutter Health, Sunnyvale, California, 94086, United States|California Dermatology Institute, Thousand Oaks, California, 91320, United States|Clarity Dermatology, Castle Rock, Colorado, 80109, United States|Siperstein Dermatology Group, Boynton Beach, Florida, 33437, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Dermatologic Surgery Center of Washington, Chevy Chase, Maryland, 20815, United States|Maryland Laser, Skin & Vein Institute, Hunt Valley, Maryland, 21030, United States|University Of Massachusetts, Worcester, Massachusetts, 01605, United States|Hamzavi Dermatology, Canton, Michigan, 48187, United States|Henry Ford Health, Detroit, Michigan, 48202, United States|Grekin Skin Institute, Warren, Michigan, 48088, United States|The Dermatology Specialist, New York, New York, 10012, United States|Mount Sinai, New York, New York, 10028, United States|Dermatology, Laser and Vein Specialists of the Carolinas, Charlotte, North Carolina, 28207, United States"
NCT05706636,T Central Memory Cells in Early Localized Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT05706636,NO,Vitiligo,DRUG: oral mini pulse|DRUG: Topical cream|DEVICE: targeted phototherapy,ALL,"CHILD, ADULT",NA,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt"
NCT06209138,5-fluorouracil for Treatment of Stable Vitiligo,https://clinicaltrials.gov/study/NCT06209138,NO,Vitiligo,DRUG: 5 fluorouracil|OTHER: Saline,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Al-Azhar University, Assiut, No State, Egypt"
NCT06446063,Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.,https://clinicaltrials.gov/study/NCT06446063,NO,Vitiligo,OTHER: Test product|OTHER: Control Product,ALL,"ADULT, OLDER_ADULT",,"COSDERMA, Bordeaux, Gironde, 33000, France"
NCT05233735,Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05233735,NO,Vitiligo,OTHER: Enhanced Transcutaneous Delivery of Topical Betamethasone after the treatment with Tixel|OTHER: Topical treatment,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, Tel Aviv Sourasky medical center, Tel Aviv, 64239, Israel"
NCT06163326,A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT06163326,NO,Vitiligo,DRUG: Ritlecitinib|DRUG: Ritlecitinib 100 mg|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Marvel Clinical Research, Huntington Beach, California, 92647, United States|Wallace Medical Group, Inc, Los Angeles, California, 90056, United States|Encore Medical Research of Boynton Beach, Boynton Beach, Florida, 33436, United States|Skin Care Research, Hollywood, Florida, 33021, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|DelRicht Research, Baton Rouge, Louisiana, 70809, United States|Visage Dermatology and Aesthetic Center, Largo, Maryland, 20774, United States|Accellacare - Wilmington, Wilmington, North Carolina, 28411, United States|Wilmington Health, PLLC, Wilmington, North Carolina, 28411, United States|Remington Davis Clinical Research, Columbus, Ohio, 43215, United States|Remington-Davis, Inc, Columbus, Ohio, 43215, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|CARe Clinic, Red Deer, Alberta, T4P 1K4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L4Y 4C5, Canada|North York Research Inc, Toronto, Ontario, M2N3A6, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Huashan Hospital Fudan University, Shanghai, Shanghai, 200040, China|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Tohoku University Hospital, Sendai-shi, Miyagi, 980-8574, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka, 593-8324, Japan|Nippon Medical School Hospital, Bunkyo-ku, Tokyo, 113-8603, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Ajou University Hospital, Suwon, Kyǒnggi-do, 16499, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul], 03722, Korea, Republic of|DermoDent Centrum Medyczne Aldona Czajkowska Rafał Czajkowski s.c., Osielsko, Kujawsko-pomorskie, 86-031, Poland|Royalderm Agnieszka Nawrocka, Warszawa, Mazowieckie, 02-962, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, Świętokrzyskie, 27-400, Poland"
NCT06097494,Investigating Healthcare Disparities in Vitiligo,https://clinicaltrials.gov/study/NCT06097494,NO,Vitiligo,OTHER: No intervention,ALL,"CHILD, ADULT, OLDER_ADULT",,"Momentum Data Limited, London, United Kingdom"
NCT05577637,Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05577637,NO,Vitiligo,DRUG: 0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily,ALL,ADULT,PHASE1,"cmh Abbottabad, Abbottabad, Khyber Pakhtunkhwa, 22020, Pakistan"
NCT05991596,Vitiligo and Psychodrama Therapy,https://clinicaltrials.gov/study/NCT05991596,NO,Vitiligo,BEHAVIORAL: Psychodramatic psychotherapy|BEHAVIORAL: Self-help activities,ALL,ADULT,NA,"APSS Trento, Trento, Italy"
NCT06394349,Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo,https://clinicaltrials.gov/study/NCT06394349,NO,Vitiligo,COMBINATION_PRODUCT: PRP+308nm|COMBINATION_PRODUCT: NS+308nm,ALL,"ADULT, OLDER_ADULT",NA,"Huashan Hospital, Shanghai, Shanghai, 200040, China"
NCT06118411,A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo,https://clinicaltrials.gov/study/NCT06118411,NO,Vitiligo,DRUG: Upadacitinib|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Advanced Research Associates - Glendale /ID# 259915, Glendale, Arizona, 85308, United States|Alliance Dermatology and MOHs Center, PC /ID# 259926, Phoenix, Arizona, 85032, United States|Private Practice - Dr. Joseph Raoof /ID# 260055, Encino, California, 91436, United States|Vitiligo & Pigmentation Institute of Southern California /ID# 259970, Los Angeles, California, 90036-5679, United States|Dermatology Research Associates /ID# 260056, Los Angeles, California, 90045, United States|Integrative Skin Science and Research /ID# 260060, Sacramento, California, 95815, United States|Clinical Trials Research Institute /ID# 259910, Thousand Oaks, California, 91320-2130, United States|Skin Care Research - Boca Raton /ID# 260094, Boca Raton, Florida, 33486-2269, United States|Apex Clinical Trials /ID# 260096, Brandon, Florida, 33511, United States|Florida Academic Dermatology Center /ID# 259919, Coral Gables, Florida, 33134-5755, United States|Encore Medical Research LLC /ID# 259963, Hollywood, Florida, 33021-6476, United States|Skin Care Research - Hollywood /ID# 260101, Hollywood, Florida, 33021-6748, United States|Life Clinical Trials /ID# 260097, Margate, Florida, 33063-5704, United States|GSI Clinical Research, LLC /ID# 259918, Margate, Florida, 33063, United States|Savin Medical Group, LLC /ID# 259968, Miami Lakes, Florida, 33014-2490, United States|Advanced Clinical Research Institute /ID# 260058, Tampa, Florida, 33607, United States|Encore Medical Research of Weston LLC /ID# 260542, Weston, Florida, 33331-3642, United States|Cleaver Medical Group /ID# 259925, Dawsonville, Georgia, 30534, United States|DeNova Research /ID# 260611, Chicago, Illinois, 60611, United States|Dawes Fretzin, LLC /ID# 260068, Indianapolis, Indiana, 46256, United States|Oakland Hills Dermatology /ID# 260602, Auburn Hills, Michigan, 48326-4600, United States|Hamzavi Dermatology - Canton /ID# 260545, Canton, Michigan, 48187, United States|Michigan Center for Research Company /ID# 260069, Clarkston, Michigan, 48346, United States|Minnesota Clinical Study Center /ID# 260154, New Brighton, Minnesota, 55112, United States|DermResearchCenter of New York, Inc. /ID# 259906, Stony Brook, New York, 11790, United States|Schweiger Dermatology, P.C. /ID# 260152, Verona, New York, 07044-2946, United States|ClinOhio Research Services /ID# 260300, Columbus, Ohio, 43213-4440, United States|Oregon Dermatology and Research Center /ID# 259917, Portland, Oregon, 97210, United States|Bellaire Dermatology Associates /ID# 260044, Bellaire, Texas, 77401, United States|Dermatology Treatment and Research Center /ID# 260078, Dallas, Texas, 75230, United States|Derm Clin Res Ctr San Antonio /ID# 260047, San Antonio, Texas, 78229, United States|Progressive Clinical Research /ID# 260070, San Antonio, Texas, 78229, United States|Dermatology and Ophthalmology Kume Clinic /ID# 260555, Sakai-shi, Osaka, 5938324, Japan|Tokyo Medical University Hospital /ID# 260552, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamagata University Hospital /ID# 260553, Yamagata-shi, Yamagata, 990-9585, Japan|Yamanashi Prefectural Central Hospital /ID# 260554, Kofu-shi, Yamanashi, 400-8506, Japan|Dr. Samuel Sanchez PSC /ID# 260090, Caguas, 00727, Puerto Rico|Mindful Medical Research /ID# 260092, San Juan, 00918-3756, Puerto Rico"
NCT06068218,Translational Assessment of Vitiligo According to Body Locations,https://clinicaltrials.gov/study/NCT06068218,NO,Vitiligo,OTHER: Biopsy for the patient group|OTHER: biopsy for the volunteer group,ALL,"ADULT, OLDER_ADULT",NA,"CHU de Nice - Hôpital de l'Archet, Nice, Alpes-maritimes, 06200, France"
NCT05549869,Assessment of Serum Leptin in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05549869,NO,Vitiligo,DIAGNOSTIC_TEST: serum leptin,ALL,"ADULT, OLDER_ADULT",NA,"Sohag University Hospital, Sohag, Egypt"
NCT06454461,Efficacy of Upadacitinib After NECS in Vitiligo,https://clinicaltrials.gov/study/NCT06454461,NO,Vitiligo,DRUG: Upadacitinib 15 MG,ALL,ADULT,NA,
NCT05342519,Daily Topical Rapamycin for Vitiligo,https://clinicaltrials.gov/study/NCT05342519,NO,Vitiligo,DRUG: Rapamycin|DRUG: Rapamycin|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"Medical University of South Carolina, Charleston, South Carolina, 29425, United States"
NCT06261073,Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients,https://clinicaltrials.gov/study/NCT06261073,NO,Vitiligo,DIAGNOSTIC_TEST: blood sample and tissue biopsy,ALL,ADULT,NA,
NCT03611348,Microneedling and Latanoprost in Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT03611348,NO,Vitiligo,DRUG: Latanoprost|DEVICE: Microneedling,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,
NCT05290077,Role of NGAL in Vitiligo,https://clinicaltrials.gov/study/NCT05290077,NO,Vitiligo,DIAGNOSTIC_TEST: NGAL,ALL,"ADULT, OLDER_ADULT",NA,"Sohag fuculty, Sohag, Egypt"
NCT05927272,Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions,https://clinicaltrials.gov/study/NCT05927272,NO,Vitiligo,PROCEDURE: SKIN SAMPLES|PROCEDURE: BLOOD SAMPLES|DEVICE: narrowband UVB|DRUG: Systemic Steroids,ALL,"ADULT, OLDER_ADULT",NA,"University Hospital of Bordeaux - St André Hospital, Bordeaux, 33000, France"
NCT05836441,Improved Phototherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT05836441,NO,Vitiligo,RADIATION: Exposure to white patches|RADIATION: Exposure to edge of white patches and normal skin around white patches,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"The first Affiliated hospital with Nanjing medical university, Nanjing, Jiangsu, 210009, China"
NCT05917561,Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT05917561,NO,Vitiligo,DRUG: Anifrolumab Infusion Product|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Bordeaux, Bordeaux, 33075, France|Centre Hospitalier Régional Le Mans, Le Mans, 72037, France|Centre Hospitalier Universitaire de Nice, Nice, 06000, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, 31059, France"
NCT05506995,Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in Vitiligo,https://clinicaltrials.gov/study/NCT05506995,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Dermatology Department. Hospital Central ""Dr. Ignacio Morones Prieto"", San Luis Potosí, 78290, Mexico"
NCT05298033,"Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo",https://clinicaltrials.gov/study/NCT05298033,NO,Vitiligo,DRUG: Crisaborole 2 % Topical Ointment|DRUG: PF-07038124 0.01% topical ointment|DEVICE: NBUVB phototherapy|DEVICE: Sham phototherapy|DRUG: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of Colorado Anschutz - Clinical and Translational Research Centers, Aurora, Colorado, 80045, United States"
NCT04843059,ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation,https://clinicaltrials.gov/study/NCT04843059,NO,Vitiligo,OTHER: The resident memory T-cell infiltrate in perilesional vitiligo skin,ALL,ADULT,NA,"CHU de Nice, Nice, Alpes Maritimes, 06001, France|CHU Bordeaux, Bordeaux, 33440, France"
NCT05812079,Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo,https://clinicaltrials.gov/study/NCT05812079,NO,Vitiligo,DIAGNOSTIC_TEST: skin biopsy examined by ELISA technique,ALL,ADULT,,
NCT05247489,A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT05247489,NO,Vitiligo,DRUG: Ruxolitinib 1.5% cream|DEVICE: NB-UVB phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,"First Oc Dermatology, Fountain Valley, California, 92708, United States|UC Davis Health, Sacramento, California, 95816, United States|Palo Alto Medical Foundation, Sunnyvale, California, 94086, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Principle Research Solutions, Spokane, Washington, 99202, United States|Simcomed Health Ltd, Barrie, Ontario, L4M 7G1, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada"
NCT05223738,Resident Memory T Cells in Vitiligo,https://clinicaltrials.gov/study/NCT05223738,NO,Vitiligo,,ALL,ADULT,,"Kasr El Ainy University hospital, Cairo, Egypt"
NCT04374435,Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04374435,NO,Vitiligo,PROCEDURE: MKTP with Surgical blade|DEVICE: MKTP with Negative Pressure Instrument|DEVICE: Suction blister grafting without cell dissociation,ALL,"ADULT, OLDER_ADULT",NA,"University of California, Irvine, Irvine, California, 92697, United States"
NCT04896385,A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA),https://clinicaltrials.gov/study/NCT04896385,YES,Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"First Oc Dermatology, Fountain Valley, California, 92708, United States|UC Irvine, Irvine, California, 92697, United States|George Washington Medical Faculty Associates, Washington, District of Columbia, 20037, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Mount Sinai Hospital, New York, New York, 10029, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|JRB Research Inc, Ottawa, Ontario, K1H 7X8, Canada|Hopital Saint Andre, Bordeaux, 33000, France|Centre Hospitalier Universitaire Henri Mondor, Creteil, 94010, France|Hopital Archet 2 Derm Dept, Nice, 06200, France"
NCT06410898,Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT06410898,NO,Vitiligo,DEVICE: Punch Biopsy 5mm,ALL,"ADULT, OLDER_ADULT",NA,"Sohag University hospitals, Sohag, Egypt"
NCT04858152,Hair Transplantation for Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT04858152,NO,Vitiligo,PROCEDURE: Follicular Unit Extraction via punch biopsy,ALL,"ADULT, OLDER_ADULT",NA,"University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States"
NCT04271501,Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04271501,NO,Vitiligo,PROCEDURE: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:5 and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:10 and Ultraviolet Lamp (UVB)|DEVICE: RECELL 1:20 and Ultraviolet Lamp (UVB),ALL,"ADULT, OLDER_ADULT",NA,"University of Massachusetts, Worcester, Massachusetts, 01655, United States"
NCT04237103,Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04237103,NO,Vitiligo,DRUG: Methotrexate|DRUG: Placebos,ALL,"ADULT, OLDER_ADULT",PHASE2,"Service de Dermatologie - Hôpital Saint-André, Bordeaux, 33075, France|Centre Hospitalier de Pau, Pau, 64000, France|Centre Hospitalier de Périgueux, Périgueux, 24000, France|Service de Dermatologie - CHU de Toulouse - Hopital Purpan, Toulouse, 31059 Toulouse Cedex, France"
NCT05513924,Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo.,https://clinicaltrials.gov/study/NCT05513924,NO,Vitiligo,DRUG: Latanoprost 0.005% Ophthalmic Solution|DRUG: 5Fluorouracil,ALL,"CHILD, ADULT",PHASE2|PHASE3,"South Valley University, Qinā, Qena Governorate, 83523, Egypt"
NCT04822584,Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo,https://clinicaltrials.gov/study/NCT04822584,NO,Vitiligo,DRUG: Baricitinib Oral Product|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Service de Dermatologie - Hôpital Saint-André, Bordeaux, 33075, France|Service de dermatologie - Hôpital Henri Mondor - EA EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques), Créteil, 94010, France|Centre Hospitalier Universitaire de Nice - Service de Dermatologie, Nice, 06000, France|Service de dermatologie Centre de Référence des Maladies Rares de la Peau et des muqueuses d'origine génétique - Hôpital Larrey, Toulouse, 31059 cedex 9, France"
NCT05037981,Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo,https://clinicaltrials.gov/study/NCT05037981,NO,Vitiligo,,ALL,"CHILD, ADULT",,
NCT04765826,"Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo",https://clinicaltrials.gov/study/NCT04765826,NO,Vitiligo,PROCEDURE: Autologous mini punch grafting,ALL,ADULT,NA,"Alexandria faculty of medicine, Alexandria, Egypt"
NCT04775979,Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo,https://clinicaltrials.gov/study/NCT04775979,NO,Vitiligo,DRUG: diphenylcyclopropenone (DPCP),ALL,"ADULT, OLDER_ADULT",PHASE4,"University hospitals faculty of medicine ain shams university, Cairo, Egypt"
NCT05121532,Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05121532,NO,Vitiligo,DIAGNOSTIC_TEST: Interleukin-15 and Interleukin-22,ALL,"CHILD, ADULT, OLDER_ADULT",NA,
NCT04030988,Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB,https://clinicaltrials.gov/study/NCT04030988,NO,Vitiligo,DRUG: Oral dexamethasone minipulse|DRUG: Placebo oral tablet,ALL,"CHILD, ADULT",PHASE1,"Ain Shams University, Cairo, Abbaseya, 00202, Egypt"
NCT03872804,Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT03872804,NO,Vitiligo,PROCEDURE: Autologous punch mini grafts:|PROCEDURE: Transverse needling|PROCEDURE: Punch minigrafts followed by transverse needling|OTHER: Oral pulse steroid with narrow band,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Omneya abd el aziz el zagh, Alexandria, 21500, Egypt"
NCT05287776,E-cadherin and Integrin Alpha v Beta 1 in Vitiligo,https://clinicaltrials.gov/study/NCT05287776,NO,Vitiligo,DEVICE: Narrow band UVB,ALL,ADULT,NA,"Kasr El Ainy university hospital, Faulty of medicine,Cairo university, Cairo, El Manial, 11956, Egypt"
NCT04338581,Evaluation of AMG 714 for Vitiligo,https://clinicaltrials.gov/study/NCT04338581,NO,Vitiligo,BIOLOGICAL: AMG 714|BIOLOGICAL: Placebo|PROCEDURE: nbUVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California, Irvine: Department of Dermatology, Irvine, California, 92697, United States|University of California Davis Health System: Department of Dermatology, Sacramento, California, 95816, United States|Yale University School of Medicine: Department of Dermatology, New Haven, Connecticut, 06824, United States|Tufts Medical Center: Department of Dermatology, Boston, Massachusetts, 02111, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Northwell Health, Lake Success, New York, 11042, United States|Perelman School of Medicine, University of Pennsylvania: Department of Dermatology, Philadelphia, Pennsylvania, 19104, United States"
NCT03099304,A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo,https://clinicaltrials.gov/study/NCT03099304,YES,Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"UNIVERSITY OF ALABAMA AT BIRMINGHAM (UAB), 1802 6th Ave S, Birmingham, Alabama, 35233, United States|BURKE PHARMACEUTICAL RESEARCH LLC, 3633 Central Ave, Hot Springs, Arkansas, 71913, United States|NORTHWEST AR CLINICAL TRIALS CENTER, PLLC/HULL DERMATOLOGY, PA, 500 S 52nd Street, Rogers, Arkansas, 72758, United States|THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA, 5670 Wilshire Boulevard, Los Angeles, California, 90036, United States|DERMATOLOGY RESEARCH ASSOCIATES- LOS ANGELES, 8930 S Sepulveda Blvd, Los Angeles, California, 90045, United States|DERMATOLOGY SPECIALISTS, 3629 Vista Way, Oceanside, California, 92056, United States|CLINICAL RESEARCH CENTER OF CT, 27 Hospital Avenue, Danbury, Connecticut, 06810, United States|LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC/ AMERIDERM RESEARCH, 725 W Granada Blvd, Ormond Beach, Florida, 32174, United States|EMORY UNIVERSITY, 1525 Clifton Road, Atlanta, Georgia, 30322, United States|NORTHWESTERN UNIVERSITY, 676 N Saint Clair, Chicago, Illinois, 60611, United States|DAWES FRETZIN CLINICAL RESEARCH GROUP, 8103 Clearvista Parkway, Indianapolis, Indiana, 46256, United States|DS RESEARCH, 2241 Green Valley Road, New Albany, Indiana, 47150, United States|TULANE UNIVERSITY, 1415 Tulane Avenue, New Orleans, Louisiana, 70112, United States|Tufts Medical Center, 260 Tremont Street, Boston, Massachusetts, 02111, United States|UNIVERSITY OF MASSACHUESETTS, 364 Plantation Street, Worcester, Massachusetts, 01605, United States|HAMZAVI DERMATOLOGY, 3031 W Grand Blvd, Detroit, Michigan, 48059, United States|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE DERMATOLOGY, 969 N. Mason Road, Saint Louis, Missouri, 63141, United States|ACTIVMED PRACTICES & RESEARCH, INC, 110 Corporate Drive, Portsmouth, New Hampshire, 03801, United States|ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MEDICAL CENTER- DERMATOLOGY ASSOCIATES, 5 E 98th Street, New York, New York, 11209, United States|WAKE FOREST UNIVERSITY HEALTH SCIENCES, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, United States|CENTRAL SOONER RESEARCH, 900 N Porter Ave, Norman, Oklahoma, 73071, United States|RHODE ISLAND HOSPITAL, 593 Eddy Street, Providence, Rhode Island, 02903, United States|ARLINGTON RESEARCH CENTER, INC., 711 East Lamar Boulevard, Arlington, Texas, 76011, United States|MENTER DERMATOLOGY RESEARCH INSTITUTE, 3900 Junius Street, Dallas, Texas, 75246, United States|UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, DEPARTMENT OF DERMATOLOGY, 5323 Harry Hines Blvd, Dallas, Texas, 75390, United States|THE DERMATOLOGY AND LASER CENTER OF SAN ANTONIO, 7810 Louis Pasteur, San Antonio, Texas, 78229, United States"
NCT05053022,A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT05053022,NO,Vitiligo,DEVICE: Skinpen Precision System,ALL,ADULT,NA,"Crown Laboratories, Dallas, Texas, 75234, United States"
NCT04738149,"Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment",https://clinicaltrials.gov/study/NCT04738149,NO,Vitiligo,DRUG: Bimatoprost|DEVICE: Excimer laser|DEVICE: Microneedling with a dermaroller,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,"Medical University of South Carolina, Charleston, South Carolina, 29407, United States"
NCT03411135,Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score,https://clinicaltrials.gov/study/NCT03411135,NO,Vitiligo,OTHER: VES and VASI scores as assessment methods for vitiligo,ALL,"ADULT, OLDER_ADULT",,
NCT02962180,Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo,https://clinicaltrials.gov/study/NCT02962180,NO,Vitiligo,DEVICE: Dermabrasion with dermaroller,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, Ibn Sina University Hospital, Rabat, 10000, Morocco"
NCT01082393,Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis),https://clinicaltrials.gov/study/NCT01082393,NO,Vitiligo,DRUG: topical tacrolimus treatment|DRUG: topical pimecrolimus treatment|DRUG: local mometasone furoate treatment|DRUG: cold cream,ALL,"ADULT, OLDER_ADULT",PHASE4,"University Hospital Ghent, Ghent, Belgium"
NCT05872477,Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas,https://clinicaltrials.gov/study/NCT05872477,NO,Vitiligo,DRUG: Ruxolitinib Topical|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice - Hôpital de l'Archet, Nice, Alpes-maritimes, 06200, France"
NCT03123016,Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03123016,NO,Vitiligo,DRUG: Apremilast|PROCEDURE: NB-UVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States"
NCT03036995,Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO,https://clinicaltrials.gov/study/NCT03036995,NO,Vitiligo,DRUG: Apremilast|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice - Dermatologie - Hôpital Archet, Nice, Alpes-Maritimes, 06, France"
NCT03864315,"To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-individual, Left-right Comparison Study",https://clinicaltrials.gov/study/NCT03864315,NO,Vitiligo,DEVICE: HGM,ALL,"ADULT, OLDER_ADULT",NA,"National Taiwan University Hospital, Taipei, 10002, Taiwan"
NCT05008887,Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05008887,NO,Vitiligo,DRUG: Methotrexate|DRUG: 5-fluorouracil|DEVICE: Fractional CO2 laser,ALL,"ADULT, OLDER_ADULT",PHASE4,
NCT01051687,Botulinum Toxin Treatment for Localized Vitiligo,https://clinicaltrials.gov/study/NCT01051687,NO,Vitiligo,DRUG: Botulinum toxin A,ALL,ADULT,PHASE4,"King Khalid University Hospital, Riyadh, 11524, Saudi Arabia"
NCT06109649,A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT06109649,NO,Vitiligo,DRUG: Afamelanotide and NB-UVB Light|PROCEDURE: NB-UVB Light,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"CLINUVEL site, Los Angeles, California, 00000, United States|CLINUVEL site, Miami, Florida, 00000, United States|CLINUVEL site, Miramar, Florida, 00000, United States|CLINUVEL site, Baton Rouge, Louisiana, 00000, United States|CLINUVEL site, Detroit, Michigan, 00000, United States|CLINUVEL site, Roseville, Minnesota, 00000, United States|CLINUVEL Site, Lee's Summit, Missouri, 00000, United States|CLINUVEL Site, Charleston, South Carolina, 00000, United States|CLINUVEL site, Thompson's Station, Tennessee, 00000, United States|CLINUVEL Site, Cedar Park, Texas, 00000, United States|CLINUVEL site, Tyler, Texas, 00000, United States|CLINUVEL site, Charlottesville, Virginia, 00000, United States|CLINUVEL site, Manchester, United Kingdom"
NCT01787708,Efficacy of Red Light in Vitiligo,https://clinicaltrials.gov/study/NCT01787708,NO,Vitiligo,PROCEDURE: Red light,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT03755830,Prostaglandin F2-alpha (PGF2α) in Vitiligo,https://clinicaltrials.gov/study/NCT03755830,NO,Vitiligo,OTHER: Skin biopsy,ALL,"ADULT, OLDER_ADULT",NA,
NCT03859518,Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo,https://clinicaltrials.gov/study/NCT03859518,NO,Vitiligo,OTHER: blood and skin samples,ALL,"ADULT, OLDER_ADULT",,"CH de Frejus, Fréjus, France"
NCT01478945,HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home,https://clinicaltrials.gov/study/NCT01478945,NO,Vitiligo,DEVICE: 311 nm NB-UVB light,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Queens Medical Centre,Nottingham University Hospitals NHS Trust, Nottingham, East Midlands, NG7 2UH, United Kingdom|Leicester Royal Infirmary, Leicester, Leicestershire, LE1 5WW, United Kingdom"
NCT02625012,Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo,https://clinicaltrials.gov/study/NCT02625012,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,
NCT02466997,Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC,https://clinicaltrials.gov/study/NCT02466997,NO,Vitiligo,DRUG: tacrolimus|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"University Hospital of Bordeaux - St André Hospital, Bordeaux, 33000, France|Regional Hospital Center of Le Mans -, Le Mans, 72000, France|University Hospital Center of Nice - Hôpital de l'Archet, Nice, 06000, France|University Hospital Center of Rennes - Hôpital Pontchaillou, Rennes, 35000, France"
NCT03832751,Human Beta-defensin 1 in Vitiligo,https://clinicaltrials.gov/study/NCT03832751,NO,Vitiligo,OTHER: skin biopsy before and after NB-UVB phototherapy,ALL,"ADULT, OLDER_ADULT",NA,
NCT05210582,A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face,https://clinicaltrials.gov/study/NCT05210582,NO,Vitiligo,DRUG: Afamelanotide,ALL,"ADULT, OLDER_ADULT",PHASE2,"CLINUVEL Investigational site, Detroit, Michigan, 48202, United States"
NCT04774809,Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo,https://clinicaltrials.gov/study/NCT04774809,NO,Vitiligo,DRUG: Low Dose SHR0302 Ointment BID|DRUG: High Dose SHR0302 Ointment BID|OTHER: Placebo Comparator: Vehicle,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China|Wuhan No.1 Hospital, Wuhan, Hubei, China|The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China|Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China|Shanghai Skin Disease Hospital, Shanghai, Shanghai, 200071, China|West China School of Medicine, Chengdu, Sichuan, China|Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, Tianjin, 300120, China|Hangzhou Third Hospital, Hangzhou, Zhejiang, China|Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Ningbo No.2 Hospital, Ningbo, Zhejiang, China|The First Hospital of Jillin University, Changchun, 130021, China|Sun. Yai- Sen Memorial Hospital, Sun. Yai- Sen University, Guangzhou, 51000, China|Zhejiang Provincial People's Hospital, Hangzhou, 310014, China|Jiangsu Province Hospital, Nanjing, 210006, China|Huashan Hospital Affiliated To Fudan University, Shanghai, China"
NCT01517893,Clinical Trial of Simvastatin to Treat Generalized Vitiligo,https://clinicaltrials.gov/study/NCT01517893,YES,Vitiligo,DRUG: Simvastatin|DRUG: Placebo,MALE,ADULT,PHASE2,"University of Massachusetts Medical School Clinical Research Center, Worcester, Massachusetts, 01655, United States"
NCT03608917,Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo,https://clinicaltrials.gov/study/NCT03608917,NO,Vitiligo,DRUG: Total Glucosides of Paeony(TGP)|DEVICE: Narrow band-ultraviolet b（NB-UVB）|DRUG: Total Glucosides of Paeony(TGP) analogue,ALL,"ADULT, OLDER_ADULT",NA,"Xijing Hospital, Xi'an, Shaanxi, 710032, China"
NCT03367273,Thymic Stromal Lymphopoietin (TSLP) in Vitiligo,https://clinicaltrials.gov/study/NCT03367273,NO,Vitiligo,OTHER: skin biopsy,ALL,"ADULT, OLDER_ADULT",NA,
NCT03497208,Comparative Study of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03497208,NO,Vitiligo,PROCEDURE: Microneedling|PROCEDURE: Cell suspension|RADIATION: Phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"HCPA, Porto Alegre, RS, 90035903, Brazil"
NCT04811131,Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo,https://clinicaltrials.gov/study/NCT04811131,NO,Vitiligo,DRUG: ARQ-252 cream 0.3%|DRUG: ARQ-252 Vehicle cream|DEVICE: NB-UVB phototherapy active treatment|DEVICE: NB-UVB phototherapy sham treatment,ALL,"ADULT, OLDER_ADULT",PHASE2,"Arcutis Site 123, San Diego, California, 92123, United States|Arcutis Site 167, Coral Gables, Florida, 33134, United States|Arcutis Clinical Site 102, Rolling Meadows, Illinois, 60008, United States|Arcutis Site 162, Austin, Texas, 78759, United States|Arcutis Clinical Site 163, Pflugerville, Texas, 78660, United States"
NCT03973073,Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT03973073,NO,Vitiligo,COMBINATION_PRODUCT: CapulinTM|OTHER: topical applications and NB-UVB,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,"Peking university people's hospital, Beijing, Beijing, 100044, China"
NCT01259986,Treatment of Vitiligo With Low-energy Visible Light Laser,https://clinicaltrials.gov/study/NCT01259986,NO,Vitiligo,PROCEDURE: Laser treatment,ALL,"ADULT, OLDER_ADULT",NA,
NCT04530344,Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04530344,YES,Vitiligo,DRUG: ruxolitinib|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|Desert Sky Dermatology, Gilbert, Arizona, 85295, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Acrc Studies, San Diego, California, 92119, United States|University of California San Francisco, San Francisco, California, 94158, United States|Colorado Medical Research Center Inc, Denver, Colorado, 80210, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|Advanced Pharma, Miami, Florida, 33147, United States|Leavitt Medical Associates of Florida, Ormond Beach, Florida, 32174, United States|Avita Clinical Research, Tampa, Florida, 33613, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|Forcare Clinical Research Fcr Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Northwestern University, Chicago, Illinois, 60611, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Tufts Medical Center, Boston, Massachusetts, 02116, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Minnesota Clinical Study Center, Minneapolis, Minnesota, 55432, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Forest Hills Dermatology Group, Kew Gardens, New York, 11415, United States|The Dermatology Specialists Greenwich, New York, New York, 10012, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Wake Research Associates Llc, Raleigh, North Carolina, 27612, United States|Wake Forest University, Winston-Salem, North Carolina, 27104, United States|Central Sooner Research, Norman, Oklahoma, 73071, United States|Kgl Skin Study Center, Broomall, Pennsylvania, 19008, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Palmetto Clinical Trial Services, Anderson, South Carolina, 29621, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Innovative Dermatology, Plano, Texas, 75024, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|The Dermatology and Laser Center of San Antonio, San Antonio, Texas, 78229, United States|Clinical Research Partners Llc, Richmond, Virginia, 23226, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Medical Center Unimed Eood, Sevlievo, 05400, Bulgaria|Diagnostic Consultative Center Ii Sofia Eood, Sofia, 01000, Bulgaria|University Multiprofile Hospital For Active Treatment Aleksandrovska, Sofia, 01431, Bulgaria|Diagnostic Consultative Center Xxviii - Sofia - Eood, Sofia, 01592, Bulgaria|Medical Center Eurohealth, Sofia, 01606, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Xlr8 Medical Research, Windsor, Ontario, N8W 1E6, Canada|Siena Medical Research Corporation, Westmount, Quebec, H3Z 2S6, Canada|Le Bateau Blanc, Martigues, 13500, France|Hopital Archet 2 Derm Dept, Nice, 06200, France|Centre Hospitalier Universitaire de Bordeaux - Hospital Haut-Leveque, Pessac, 33604, France|Hopital Charles Nicolle Chu Rouen Hospital de Bois-Guillaume, Rouen, 76031, France|Chu de Toulouse Hopital Larrey Centre de Reference Des Maladies Rares de La Peau Service de Dermatol, Toulouse, 31059, France|Universitaetsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Hautarztpraxis Mahlow, Mahlow, 15831, Germany|Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, 55131, Germany|Universitatsklinik Munster Dermatologie, Muenster, 48149, Germany|Amsterdam University Medical Centre, Amsterdam, 1100 DD, Netherlands|Synexus - Polska Sp Z Oo Oddzial W Gdansk, Gdansk, 80-382, Poland|Synexus Polska Sp. Z O.O. Oddzial W Gdyni, Gdynia, 81-537, Poland|Synexus - Sp Z Oo Oddzial W Katowice, Katowice, 40-040, Poland|Synexus Affiliate - Krakowskie Centrum Medyczne, Krakow, 31-501, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Lublin, 20-081, Poland|Dermedic Dr. Zdybski, OSTROWIEC Swietokrzyski, 27-400, Poland|Synexus Polska Sp. Z O.O. Oddzial W Poznaniu, Poznan, 60-702, Poland|Lubeskie Centrum Diagnostyczne, Swidnik, 21-040, Poland|Poradnia Dermatologiczno-Wenerologiczna Mediderm S.C. Nzoz, Torun, 87-100, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warsaw, 01-192, Poland|High-Med Przychodnia Specjalistycza, Warsaw, 01-817, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-381, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Ico Hospital Germans Trias I Pujol, Badalona, 08916, Spain|Dermomedic, Madrid, 28001, Spain|Clinica Universidad de Navarra (Cun), Pamplona, 31008, Spain"
NCT03762551,Janus Kinase 1 in Vitiligo & Psoriasis,https://clinicaltrials.gov/study/NCT03762551,NO,Vitiligo,OTHER: skin biopsy,ALL,"CHILD, ADULT, OLDER_ADULT",NA,
NCT02432534,Atorvastatin in Active Vitiligo,https://clinicaltrials.gov/study/NCT02432534,NO,Vitiligo,DRUG: Atorvastatin|OTHER: UVB,ALL,"ADULT, OLDER_ADULT",PHASE2,"CHU de Nice, Nice, Alpes-Maritimes, 06001, France|National Skin center - 1 Mandalay Rd, Bedok, Singapore, 308205, Indonesia"
NCT04547998,Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions,https://clinicaltrials.gov/study/NCT04547998,YES,Vitiligo,DEVICE: Control Intervention (UVB)|DEVICE: Investigational Interventions (Ablative Laser Resurfacing + RECELL + UVB),ALL,"ADULT, OLDER_ADULT",NA,"University of California, Irvine, Irvine, California, 92697, United States|University of California, Davis, Sacramento, California, 95817, United States|West Dermatology, San Diego, California, 92121, United States|DMR Research, Westport, Connecticut, 06880, United States|Skin Care Research, LLC, Hollywood, Florida, 33021, United States|Miami Dermatology and Laser Institute, Miami, Florida, 33173, United States|University of Massachusetts, Worcester, Massachusetts, 01581, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte, North Carolina, 28207, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|University of Texas at Austin Dell Medical School, Austin, Texas, 78712, United States|Heights Dermatology, Houston, Texas, 77008, United States"
NCT03133871,Evaluation of Scanoskin for the Assessment of Vitiligo,https://clinicaltrials.gov/study/NCT03133871,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Chelsea and Westminster Hospital, London, SW10 9NH, United Kingdom"
NCT02510651,Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02510651,NO,Vitiligo,PROCEDURE: Melanocyte-keratinocyte suspension,ALL,"ADULT, OLDER_ADULT",PHASE1,
NCT01732965,NB-UVB and PUVA Vitiligo Study,https://clinicaltrials.gov/study/NCT01732965,NO,Vitiligo,OTHER: Phototherapy|OTHER: Phototherapy and Photochemotherapy,ALL,"ADULT, OLDER_ADULT",PHASE4,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States"
NCT02797574,Stress Response Pathways in Vitiligo,https://clinicaltrials.gov/study/NCT02797574,NO,Vitiligo,PROCEDURE: Punch Biopsy at a Lesional Site|PROCEDURE: Punch Biopsy at a Non- Lesional site,ALL,ADULT,NA,"New York University School of Medicine, New York, New York, 10016, United States"
NCT00830713,Vitiligo Skin Transplantation,https://clinicaltrials.gov/study/NCT00830713,NO,Vitiligo,PROCEDURE: Melanocyte-keratinocyte transplantation procedure (MKTP),ALL,"ADULT, OLDER_ADULT",PHASE3,"Henry Ford Medical Center, New Center One, Detroit, Michigan, 48202, United States"
NCT02290717,Fractional Laser in Combination With UVB Therapy in Vitiligo Patients,https://clinicaltrials.gov/study/NCT02290717,NO,Vitiligo,DEVICE: Fractional CO2 laser|OTHER: NB-UVB therapy|DRUG: Fluticasone Propionate Cream 0.05%,ALL,"ADULT, OLDER_ADULT",NA,"Academic Medical Centre, Amsterdam, Netherlands"
NCT04103060,"Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo",https://clinicaltrials.gov/study/NCT04103060,NO,Vitiligo,DRUG: Cerdulatinib 0.37% gel|DRUG: Vehicle gel,ALL,"ADULT, OLDER_ADULT",PHASE2,"Dermavant Investigational Site, Irvine, California, 92617, United States|Dermavant Investigational Site, Worcester, Massachusetts, 01605, United States"
NCT01766609,Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01766609,NO,Vitiligo,DRUG: Triamcinolone Acetonide,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT04171427,Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT04171427,NO,Vitiligo,OTHER: Lithium liposome|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",NA,"Hbib thamer Hospital, Tunis, Tunisia"
NCT03941808,Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.,https://clinicaltrials.gov/study/NCT03941808,NO,Vitiligo,DRUG: Glisodin tablet|DRUG: Placebo tablet,ALL,"ADULT, OLDER_ADULT",NA,"Passeron, Nice, Alpes-Maritime, 06001, France"
NCT03717025,Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients,https://clinicaltrials.gov/study/NCT03717025,NO,Vitiligo,PROCEDURE: SUCTION BLISTER EPIDERMAL GRAFTING|PROCEDURE: MINI PUNCH GRAFTING|PROCEDURE: NON CULTURED EPIDERMAL CELL SUSPENSION,ALL,"ADULT, OLDER_ADULT",NA,"Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India"
NCT04525157,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT04525157,YES,Vitiligo,DRUG: Afamelanotide|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT04320160,Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo,https://clinicaltrials.gov/study/NCT04320160,NO,Vitiligo,PROCEDURE: Platelet rich plasma|PROCEDURE: Fractional CO2 laser,ALL,ADULT,NA,
NCT00696358,Excimer Lamp Versus Excimer Laser in Vitiligo Treatment,https://clinicaltrials.gov/study/NCT00696358,NO,Vitiligo,RADIATION: 308nm excimer lamp|RADIATION: 308nm excimer laser,ALL,"ADULT, OLDER_ADULT",PHASE3,"Department of Dermatology, University Hospital of Nice, Nice, 06200, France"
NCT02809976,Topical Ruxolitinib for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02809976,YES,Vitiligo,DRUG: Ruxolitinib 1.5% Phosphate Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Tufts Medical Center, Boston, Massachusetts, 02111, United States"
NCT01923142,Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01923142,NO,Vitiligo,BIOLOGICAL: Outer-Root-Sheath Melanocytes Suspension|BIOLOGICAL: Placebo,ALL,ADULT,PHASE2,"Papa Giovanni XXIII Hospital, Bergamo, 24127, Italy|Spedali Civili, Brescia, 25123, Italy"
NCT03468855,A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03468855,YES,Vitiligo,DRUG: ATI-50002 topical solution,ALL,"ADULT, OLDER_ADULT",PHASE2,"Aclaris Investigator Site, Encinitas, California, 92024, United States|Aclaris Investigator Site, Los Angeles, California, 90036, United States|Aclaris Investigator Site, Worcester, Massachusetts, 01655, United States|Aclaris Investigator Site, Dallas, Texas, 75390, United States|Aclaris Investigator Site, Lynchburg, Virginia, 24501, United States"
NCT03155698,Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma,https://clinicaltrials.gov/study/NCT03155698,NO,Vitiligo,COMBINATION_PRODUCT: microneedling and Platelet rich plasma|RADIATION: NB-UVB phototherapy,ALL,ADULT,NA,"Assiut university, Assiut, Egypt"
NCT01419964,Efficacy and Safety of ACH24 in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01419964,NO,Vitiligo,DRUG: Group 01|DRUG: Group 02,ALL,"ADULT, OLDER_ADULT",PHASE3,"Irmandade da Santa Casa de Misericórdia de Curitiba, Curitiba, Paraná, 80010-030, Brazil"
NCT02925767,Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo,https://clinicaltrials.gov/study/NCT02925767,NO,Vitiligo,DEVICE: 311-nm Ti:Sapphire laser|DEVICE: 308-nm excimer laser,ALL,"ADULT, OLDER_ADULT",NA,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of"
NCT01992185,Photocil (Topical) for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01992185,YES,Vitiligo,DRUG: Photocil for Vitiligo|OTHER: Placebo - Sunscreen (SPF 2),ALL,"ADULT, OLDER_ADULT",NA,"Physicians Institute, Tucson, Arizona, 85719, United States"
NCT03199664,Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03199664,NO,Vitiligo,RADIATION: NB-UVB|COMBINATION_PRODUCT: NB-UVB & Tacrolimus 0.03%,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"South valley university, Qinā, Egypt"
NCT03158675,"Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo",https://clinicaltrials.gov/study/NCT03158675,NO,Vitiligo,PROCEDURE: fractional carbon dioxide(CO2) laser|DRUG: Topical corticosteroid|RADIATION: Ultraviolet B narrow band,ALL,"CHILD, ADULT, OLDER_ADULT",NA,
NCT02281058,Open-label Pilot Study of Abatacept for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT02281058,NO,Vitiligo,DRUG: Abatacept,ALL,"ADULT, OLDER_ADULT",PHASE1,"Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States"
NCT03013049,A Novel Surgical Method in the Treatment of Unstable Vitiligo,https://clinicaltrials.gov/study/NCT03013049,NO,Vitiligo,PROCEDURE: Non cultured epidermal cell suspension|PROCEDURE: Non cultured dermal cell suspension,ALL,"ADULT, OLDER_ADULT",NA,"PGIMER, Chandigarh, 160012, India"
NCT01382589,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo,https://clinicaltrials.gov/study/NCT01382589,NO,Vitiligo,DRUG: Afamelanotide|DEVICE: NB-UVB,ALL,"ADULT, OLDER_ADULT",PHASE2,
NCT01430195,Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV),https://clinicaltrials.gov/study/NCT01430195,NO,Vitiligo,DRUG: Afamelanotide|PROCEDURE: Narrow-Band UVB Light Treatment,ALL,"ADULT, OLDER_ADULT",PHASE1,"Henry Ford Medical Center, Detroit, Michigan, 48202, United States|The Mount Sinai School of Medicine, New York, New York, 10029, United States"
NCT01333410,Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo,https://clinicaltrials.gov/study/NCT01333410,NO,Vitiligo,DRUG: tacrolimus ointment|DRUG: Mometasone furoate,ALL,"ADULT, OLDER_ADULT",PHASE4,"Department of Dermatology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand"
NCT01629979,Epidermal Cell Transplantation in Vitiligo Skin,https://clinicaltrials.gov/study/NCT01629979,NO,VITILIGO,PROCEDURE: Grafting with epidermal cells|RADIATION: UVB treatment,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Centre hospitalier Universitaire de Nice, Nice, 06000, France"
NCT03249064,Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo,https://clinicaltrials.gov/study/NCT03249064,NO,VITILIGO,DIAGNOSTIC_TEST: CD 91 levels|DIAGNOSTIC_TEST: Tregs,ALL,"ADULT, OLDER_ADULT",,"Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain"
NCT03741738,"The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity",https://clinicaltrials.gov/study/NCT03741738,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, 03722, Korea, Republic of"
NCT00807690,Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo,https://clinicaltrials.gov/study/NCT00807690,NO,Vitiligo,DRUG: Tacrolimus ointment,ALL,"ADULT, OLDER_ADULT",PHASE3,
NCT02191748,Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo,https://clinicaltrials.gov/study/NCT02191748,NO,Vitiligo,PROCEDURE: Needling|DRUG: Triamcinolone,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"RWJUH Dermatology office, Somerset, New Jersey, 08873, United States"
NCT03668834,"Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in Non Cultured Epidermal Cell Suspension in Stable Vitiligo",https://clinicaltrials.gov/study/NCT03668834,NO,Vitiligo,PROCEDURE: Dermabrasion with NCES|PROCEDURE: Dermaroller with NCES|PROCEDURE: Liquid nitrogen induced blister with NCES,ALL,"ADULT, OLDER_ADULT",NA,"PGIMER, Chandigarh, 160012, India"
NCT00615355,Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment,https://clinicaltrials.gov/study/NCT00615355,NO,Vitiligo,RADIATION: UVB 311 nm radiation|DEVICE: UVB 311nm,ALL,"ADULT, OLDER_ADULT",NA,"Medical University, Department of Dermatology, Graz, 8036, Austria"
NCT00134368,Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo,https://clinicaltrials.gov/study/NCT00134368,NO,Vitiligo,DRUG: Etanercept,ALL,"ADULT, OLDER_ADULT",PHASE2,"UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, 08903, United States"
NCT00367224,Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00367224,NO,Vitiligo,PROCEDURE: 6 to 9 ultraviolet B treatments|PROCEDURE: Skin biopsies,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology/Henry Ford Hospital, Detroit, Michigan, 48202, United States"
NCT01787695,UVA 1 Phototherapy for Vitiligo,https://clinicaltrials.gov/study/NCT01787695,NO,Vitiligo,PROCEDURE: UVA1,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT01459055,Long-term Follow-up in Patients Affected With Acrofacial Vitiligo,https://clinicaltrials.gov/study/NCT01459055,NO,Vitiligo,,ALL,"ADULT, OLDER_ADULT",,"Irmandade da Santa Casa de Misericórdia de Curitiba, Curitiba, Parana, 80730000, Brazil"
NCT00368407,Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck,https://clinicaltrials.gov/study/NCT00368407,NO,Vitiligo,DEVICE: 308-nm excimer laser,ALL,"CHILD, ADULT",,"Department of dermatology, Xijing Hospital, Xi'an, SHANNXI, 710032, China"
NCT01262547,A New Micrografting Technique for Vitiligo,https://clinicaltrials.gov/study/NCT01262547,YES,Vitiligo,DEVICE: Dermabrasion-Micrografting|PROCEDURE: Dermabrasion,ALL,"ADULT, OLDER_ADULT",PHASE2,"Mgh Curtis, Boston, Massachusetts, 02114, United States"
NCT00622180,The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands,https://clinicaltrials.gov/study/NCT00622180,YES,Vitiligo,DEVICE: NBUVB|DEVICE: Monochromacitc Excimer light,ALL,"ADULT, OLDER_ADULT",NA,"UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, 75390-8802, United States"
NCT01822379,Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01822379,NO,Vitiligo,PROCEDURE: Melanocyte Keratinocyte transplantation,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"Henry Ford Hospital Department of Dermatology, Detroit, Michigan, 48202, United States"
NCT00631865,Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin,https://clinicaltrials.gov/study/NCT00631865,NO,Vitiligo,BIOLOGICAL: Melanocyte transplantation,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Royan Institute, Tehran, 1665659911, Iran, Islamic Republic of"
NCT00380471,Treatment and Complication of Bath PUVA in Vitiligo,https://clinicaltrials.gov/study/NCT00380471,NO,Vitiligo,DEVICE: Bath PUVA,ALL,"ADULT, OLDER_ADULT",PHASE2,"Skin Research Center, Shaheed Beheshti Medical University, Tehran, 19899, Iran, Islamic Republic of"
NCT03022019,ReNovaCell in Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT03022019,NO,Non-segmental Vitiligo|Vitiligo,DEVICE: ReNovaCell,ALL,"ADULT, OLDER_ADULT",NA,"Nipd / Amc, Amsterdam, 1105AZ, Netherlands"
NCT00398723,Narrowband UVB Treatment in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT00398723,NO,Vitiligo,DEVICE: Narrowband UVB,ALL,"ADULT, OLDER_ADULT",NA,"Rockefeller University Hospital, New York, New York, 10021, United States"
NCT06261086,Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study,https://clinicaltrials.gov/study/NCT06261086,NO,Vitiligo,"DIAGNOSTIC_TEST: evaluate serum levels pyroptosis-related indicators (GASDM-D, IL 1β & IL-18)",ALL,"ADULT, OLDER_ADULT",NA,
NCT01006421,Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01006421,NO,Vitiligo,DIETARY_SUPPLEMENT: GINGKO BILOBA,ALL,"CHILD, ADULT, OLDER_ADULT",,"King Khalid University Hospital, Riyadh, Central, Saudi Arabia"
NCT05467839,Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients,https://clinicaltrials.gov/study/NCT05467839,NO,Vitiligo,DEVICE: derma pen,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Sohag University Hospital, Sohag, Egypt"
NCT00525395,Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol,https://clinicaltrials.gov/study/NCT00525395,NO,Vitiligo,GENETIC: Sequential phototherapy|PROCEDURE: Continuous phototherapy,ALL,ADULT,PHASE3,"Istituto San Gallicano -, Rome, 00100, Italy"
NCT00172939,Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model,https://clinicaltrials.gov/study/NCT00172939,NO,Vitiligo,PROCEDURE: foreskin from healthy adults,MALE,ADULT,PHASE1,"National Taiwan University Hospital, Taipei, Taiwan"
NCT05256147,Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters,https://clinicaltrials.gov/study/NCT05256147,NO,Vitiligo,DRUG: Ibuprofen,ALL,"ADULT, OLDER_ADULT",NA,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States"
NCT00177034,Examination Of Vitiligo Skin Samples Before and After UVB Treatment,https://clinicaltrials.gov/study/NCT00177034,NO,Vitiligo,DRUG: Narrow Band UVB Treatment,ALL,"ADULT, OLDER_ADULT",NA,"University of Minnesota, Minneapolis, Minnesota, 55455, United States"
NCT01511965,Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT01511965,NO,Vitiligo,OTHER: autologous (cellular therapy),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"service de Dermatologie - Hôpital l'Archet, Nice, 06200, France"
NCT01087216,Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo,https://clinicaltrials.gov/study/NCT01087216,NO,Vitiligo,DEVICE: Group Laser = Arm A|DRUG: Bras B : The group control,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez, Nice, Alpes-Maritimes, 06001, France"
NCT03933774,"PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation",https://clinicaltrials.gov/study/NCT03933774,YES,Vitiligo,DRUG: Tretinoin 0.05% cream|DRUG: Placebo cream,ALL,"ADULT, OLDER_ADULT",NA,"St. Vincent's Hospital, Suwon, Gyeonggi-do, 16247, Korea, Republic of"
NCT01792245,Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand,https://clinicaltrials.gov/study/NCT01792245,NO,Vitiligo,DEVICE: Phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"The Skin Care Center, Vancouver General Hospital, Vancouver, British Columbia, V5Z 4E8, Canada"
NCT05676333,Secukinumab in Active Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT05676333,NO,Vitiligo|Secukinumab,DRUG: Secukinumab,ALL,"ADULT, OLDER_ADULT",PHASE4,"Department of Dermatology, Ghent University Hospital, Gent, Oost-Vlaanderen, 9000, Belgium"
NCT05980390,IL35 Level in Vitiligo,https://clinicaltrials.gov/study/NCT05980390,NO,"IL35, Vitiligo",DIAGNOSTIC_TEST: IL 35 in tissue biopsy,ALL,ADULT,,
NCT05503368,Autologous Cellular Graft in Surgical Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05503368,NO,"Vitiligo, Generalized",PROCEDURE: surgical treatment of vitiligo using NCES,ALL,"ADULT, OLDER_ADULT",NA,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt"
NCT06327321,Vitiligo Treatment by Targeting TYK2 Mediated Responses,https://clinicaltrials.gov/study/NCT06327321,NO,"Vitiligo, Generalized",DRUG: Deucravacitinib|OTHER: Volunteer without treatment,ALL,"ADULT, OLDER_ADULT",PHASE3,"CHU de Nice - Hôpital de l'Archet, Nice, Alpes-Maritimes, 06200, France|APHP, Henri Mondor, Paris, Creteil, France|CHU de Bordeaux, Bordeaux, Talence, 33000, France|CHU de Lille, Lille, France|HCL, Lyon, France"
NCT06113471,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2),https://clinicaltrials.gov/study/NCT06113471,NO,NonSegmental Vitiligo,DRUG: Povorcitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"University of Alabama At Birmingham Hospital-Whitaker Clinic, Birmingham, Alabama, 35294-0007, United States|C2 Research Center, Llc, Montgomery, Alabama, 36117, United States|Tien Q Nguyen Md Inc, Fountain Valley, California, 92708-3701, United States|Center For Dermatology Clinical Research, Inc, Fremont, California, 94538, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036-5609, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Clinical Trials Research Institute, Thousand Oaks, California, 91320, United States|Skin Care Research, Llc, Boca Raton, Florida, 33486, United States|Total Vein and Skin Llc, Boynton Beach, Florida, 33437, United States|Driven Research Llc, Coral Gables, Florida, 33134, United States|Florida Academic Centers Research and Education Llc, Coral Gables, Florida, 33134, United States|Pediatric Skin Research Llc, Coral Gables, Florida, 33146, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Advanced Medical Research Pc, Sandy Springs, Georgia, 30328, United States|Dundee Dermatology, West Dundee, Illinois, 60118, United States|Indiana University School of Medicine Iusm Indianapolis, Indianapolis, Indiana, 46202-3082, United States|Delricht Research, Baton Rouge, Louisiana, 70809, United States|Callender Dermatology and Cosmetic Center, Glenn Dale, Maryland, 20769, United States|Aesthetic and Dermatology Center, Rockville, Maryland, 20850, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Allcutis Research, Inc Portsmouth, Portsmouth, New Hampshire, 03801, United States|Weill Cornell Medicine, New York, New York, 10065, United States|Accellacare Wilmington, Wilmington, North Carolina, 28401, United States|Remington-Davis Clinical Research, Columbus, Ohio, 43215, United States|Oregon Medical Research Center, Pc, Portland, Oregon, 97223, United States|Health Concepts Rapid City, Rapid City, South Dakota, 57702, United States|Dermatology Treatment and Research Center, Dallas, Texas, 75230, United States|Heights Dermatology and Aesthetic Center, Houston, Texas, 77008, United States|University of Texas, Md Anderson Cancer, Houston, Texas, 77030, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Premier Clinical Research, Spokane, Washington, 99202, United States|Medical Center Asklepii Ood, Dupnitsa, 02600, Bulgaria|Mc Unimed, Sliven, 05308, Bulgaria|Ambulatory For Specialized Medical Care - Individual Practice For Specialized Medical Care - Skin An, Sofia, 01407, Bulgaria|Aleksandrovska University Hospital, Sofia, 01431, Bulgaria|28 Diagnostic and Consultative Center, Sofia, 01528, Bulgaria|British Columbia'S Centre For Dermatologic Science - the Skin Care Centre, Vancouver, British Columbia, V5Z 4E8, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|DERMEDGE, Mississauga, Ontario, L4Y 4C5, Canada|Research Toronto, Toronto, Ontario, M3H 5Y8, Canada|Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Centre de Recherche Dermatologique de Quebec, Quebec City, Quebec, G1V4X7, Canada|Chru Morvan/Chu Brest Hopital Morvan, Brest, 29200, France|Centre Hospitalier - Le Mans, Le Mans, 72037, France|Hopital Edouard Herrio, Lyon Cedex 03, 69003, France|Cabinet Medical- Chemin de Paradis, Martigues, 13500, France|Centre Hospitalier Universitaire de Nice,Hopital L Archet, Nice, 06200, France|Hopital Charles Nicolle, Rouen Cedex, 76031, France|Fachklinik Bad Bentheim Dermatologie, Bad Bentheim, 481455, Germany|Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, 10117, Germany|University Hospital Carl Gustav Carus, Dresden, 01307, Germany|Universitatsklinikum Hamburg, Hamburg, 20246, Germany|Dermatologische Gemeinschaftspraxis, Mahlow, 15831, Germany|Universitatsklinikum Munster, Muenster, 48149, Germany|Clinexpert Egeszsegugyi Szolgaltato Es Kereskedelmi Kft., Budapest, 01033, Hungary|Orvostudomanyi Kutato Es Fejleszto Kft, Debrecen, 04027, Hungary|Debreceni Egyetem, Debrecen, 04032, Hungary|Obudai Egeszsegugyi Centrum - Dunaujvaros, Dunaujvaros, H-2400, Hungary|Markusovszky Teaching Hospital, Szombathely, Hungary|Azienda Ospedaliera Spedali Civili Di Brescia-Universita Degli Studi Di Brescia, Brescia, 25123, Italy|Azienda Ospedaliero-Universitaria Policlinico Vittorio Emanuele Ospedale Gaspare Rodolico Di Catania, Catania, 95123, Italy|Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milano, 20122, Italy|Fondazione Policlinico Universitario Agostino Gemelli Irccs, Rome, 00168, Italy|Irccs Istituto Clinico Humanitas, Rozzano, 20089, Italy|Synexus - Polska Sp Z Oo Oddzial W Gdansksynexus Affiliate - Bialystok - Clinicmed Daniluk Nowak Spo, Gdansk, 80-382, Poland|Synexus Gdynia, Gdynia, 81-537, Poland|Provita Sp.Zo.O. Centrum Medyczne Angelius, Katowice, 40-611, Poland|Pro Familia Altera Sp. Z O.O., Katowice, 40-648, Poland|Prywatny Gabinet Dermatologiczny Elzbieta Klujszo, Kielce, 25-316, Poland|Niepubliczny Zaklad Opieki Zdrowotnej Dermed Centrum Medyczne Sp. Z O.O., Lodz, 90-265, Poland|Dermoklinika Centrum Medyczne S.C., M. Kierstan, J. Narbutt, A. Lesiak, Lodz, 90-436, Poland|Etg Skierniewice, Skierniewice, 96-100, Poland|Laser Clinic, Szczecin, 70-332, Poland|Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin, 71-434, Poland|Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. Z O.O., Tarnow, 33-100, Poland|Centrum Medyczne Evimed, Warsaw, 02-625, Poland|Royalderm Agnieszka Nawrocka, Warszawa, 02-692, Poland|Klinika Ambroziak Sp. Z O.O., Warszawa, 02-953, Poland|Futuremeds Targowek Centrum Medyczne Amed Warszawa Targowek, Wrocaw, 03-291, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-088, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Centrum Medyczne Oporow, Wroclaw, 52-416, Poland|Ipswich Hospital, East Suffolk and North Essex Nhs Foundation Trust, Ipswich, IP4 5PD, United Kingdom|University Hospitals of Leicester-Leicester Royal Infirmary (Lri), Leicester, LE1 5WW, United Kingdom|Barts Health Nhs Trust - Whipps Cross University Hospital, London, E11 1NR, United Kingdom|Nottingham University Hospitals - Treatment Center, Nottingham, NG7 2FT, United Kingdom|Royal Wolverhampton Nhs Trust, Walsall, WS2 9PS, United Kingdom"
NCT06113445,A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1),https://clinicaltrials.gov/study/NCT06113445,NO,NonSegmental Vitiligo,DRUG: Povorcitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|University of California Irvine, Irvine, California, 92697, United States|Clinical Science Institute Clinical Research Specialists Inc, Santa Monica, California, 90404, United States|Cura Clinical Research, Sherman Oaks, California, 91403, United States|Sutter Health Palo Alto Medical Foundation Pamf Sunnyvale Center, Sunnyvale, California, 94086, United States|Renaissance Research, Cape Coral, Florida, 33991, United States|Encore Medical Research, Llc Hollywood, Hollywood, Florida, 33021, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|Savin Medical Group, Rc, Miami, Florida, 33156, United States|Skin Research of South Florida, Llc, Miami, Florida, 33173, United States|Olympian Clinical Research, Tampa, Florida, 33609, United States|Forcare Clinical Research, Tampa, Florida, 33613, United States|Cleaver Medical Group, Cumming, Georgia, 30040, United States|Pivotal Research Solutions, Stonecrest, Georgia, 30038, United States|Options Research Group, Llc, Kokomo, Indiana, 46901, United States|Allcutis Research Inc Beverly, Beverly, Massachusetts, 01915, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135-3511, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Wayne State University Physician Group Dermatology, Dearborn, Michigan, 48124, United States|Revival Research Institute, Llc Dermatology, Troy, Michigan, 48084, United States|Grekin Skin Institute Warren, Warren, Michigan, 48088, United States|Medisearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Schweiger Dermatology Group - Verona, Verona, New Jersey, 07044, United States|Empire Dermatology, East Syracuse, New York, 13057, United States|Sadick Dermatology Sadick Research Group, New York, New York, 10075, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Bexley Dermatology, Bexley, Ohio, 43209, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|University of Texas Physicians - Bellaire Station, Bellaire, Texas, 77401, United States|Center For Clinical Studies, Houston, Texas, 77004, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Jordan Valley Dermatology Center, West Jordan, Utah, 84088, United States|Clinical Research Partners Llc Crp Richmond Forest Avenue Office Building Location, Richmond, Virginia, 23226, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Hopital Universitaire de Bruxelles (H.U.B)/ Academisch Ziekenhuis Brussel, Brussels, 01070, Belgium|Universitair Ziekenhuis Gent, Gent, 09000, Belgium|Centre Hospitalier Universitaire de Liege - Sart Tilman, Liege, 04000, Belgium|Cliniques Universitaires Ucl Saint-Luc, Woluwe-saint-lambert, 01200, Belgium|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Dr. Chih-Ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|Leader Research, Burlington, Ontario, L7R 4H9, Canada|Dermeffects, London, Ontario, N6H 5L5, Canada|North York Research Inc., North York, Ontario, M2M 4J5, Canada|Care Clinic, Ottawa, Ontario, K1A 0K9, Canada|Siena Medical Research Corporation, Ottawa, Ontario, K1A 0K9, Canada|Skin Health, Peterborough, Ontario, K9J 5K2, Canada|Alliance Clinical Trials, Waterloo, Ontario, N2J 1C4, Canada|Bordeaux Chu Hopital Saint - Andre, Bordeaux Cedex, 33075, France|Centre Hospitalier Universitaire (Chu) - Hopital Henri Mondor, Bordeaux Cedex, 33075, France|Clinique de Courlancy, Reims, 51100, France|Hopital Larrey, Toulouse, 31059, France|Universitatsklinikum Erlangen Hautklinik, Erlangen, 91054, Germany|Klinikum Der Johann Wolfgang Goethe University, Frankfurt Am Main, 60590, Germany|Derma-Study-Center Friedrichshafen Gmbh, Friedrichshafen, 88045, Germany|Dermatologische Gemeinschaftspraxis Dres. Quist, Mainz, 55128, Germany|Beldio Research Gmbh, Dr. Schwinn,, Memmingen, 87700, Germany|Hamamatsu University Hospital, Hamamatsu, 431-3192, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, 216-8511, Japan|Kobe University Hospital, Kobe, 6500017, Japan|University Hospital Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan|Dokkyo Medical University Saitama Medical Center, Minamikoshigaya, 343-8555, Japan|Nagasaki University Hospital, Nagasaki-shi, 852-8501, Japan|Nagoya City University Hospital, Nagoya, 467-8602, Japan|Kochi Medical School Hospital, Nankoku, 783-8505, Japan|Niigata University Medical and Dental Hospital, Niigata, 9518520, Japan|National Hospital Organization Okayama Medical Center, Okayama-shi, 701-1192, Japan|Tohoku University Hospital, Sendai, 980-8574, Japan|Ntt Medical Center Tokyo, Shinagawa-ku, 141-8625, Japan|Tokyo Medical University Hospital, Shinjuku-ku, 160-0023, Japan|Osaka University Hospital, Suita, 565-0871, Japan|National University Corporation - Tokyo Medical and Dental University (Tmdu), Tokyo, 113-8519, Japan|Juntendo University Urayasu Hospital, Urayasu, 279-0021, Japan|Yamagata University Hospital, Yamagata-shi, 990-9585, Japan|Trials in Medicine S.C., Cuauhtemoc, 06700, Mexico|Instituto de Investigaciones Aplicadas A La Neurociencia A.C, Durango, 34000, Mexico|Grupo Clínico Catei Sc, Guadalajara, 44600, Mexico|Centro de Dermatologia de Monterrey, Monterrey, 64460, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, 64660, Mexico|Clinica de Enfermedades Cronicas Y de Procedimientos Especiales (Cecype), Morelia, 58249, Mexico|Uva - Amc - Stichting Nederlands Instituut Voor Pigmentstoornissen (Snip) (Netherlands Institute For, Amsterdam, 1105 AZ, Netherlands|Bravis Ziekenhuis, Bergen Op Zoom, 4624 VT, Netherlands|Dermapolis Medical Dermatology Center Dr N. Med. Edyta Gebska, Chorzow, 41-516, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Czestochowa, 42-202, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|Synexus Polska Sp. Z O.O. Oddzial W Katowicach, Katowice, 40-040, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Dermodent Centrum Medyczne Aldona Czajkowska Rafa¿ Czajkowski, Osielsko, 86-031, Poland|Dermedic Jacek Zdybski, Ostrowiec Swietokrzyski, 27-400, Poland|Uniwersytecki Szpital Kliniczny Im. Fryderyka Chopina W Rzeszowie, Rzeszow, 35-055, Poland|Etg Warszawa, Warsaw, 02-777, Poland|Csk Mswia Centralny Szpital Kliniczny Mswia, Warszawa, 02-507, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszawa, 02-661, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warszawa, 02-672, Poland|Emc Instytut Medyczny Spolka Akcyjna-Euromedicare Szpital Specjalistyczny Z Przychodnia, Wrocaw, 54144, Poland|Hospital Universitario Fundacion Alcorcon, Alcorcon, 28922, Spain|Germans Trias I Pujol, Badalona, 08916, Spain|Hospital Clinic I Provincial, Barcelona, 08036, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Clinical Universidad de Navarra Madrid, Madrid, 31008, Spain|Hospital de Manises, Manises, 46940, Spain"
NCT05950542,"Evaluation Safety ,Efficacy Baricitinib Plus Excimer Light Versus Excimer Light Alone in Non Segmental Vitiligo",https://clinicaltrials.gov/study/NCT05950542,NO,"Vitiligo, Generalized",DRUG: Baricitinib,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT05511493,Efficacy of PRP With Er-YAG Laser Versus With Microneedling in Localized Stable Vitiligo,https://clinicaltrials.gov/study/NCT05511493,NO,Localized Vitiligo,DEVICE: fractional Erbium-YAG laser|DEVICE: microneedling,ALL,"CHILD, ADULT",NA,
NCT04440371,Phototherapy Combination With Topicals in Vitiligo,https://clinicaltrials.gov/study/NCT04440371,NO,"Vitiligo, Generalized",COMBINATION_PRODUCT: Tacrolimus 0.1% ointment twice daily plus NBUVB 3 times weekly|COMBINATION_PRODUCT: Calcipotriol/Betamethasone ointment plus NBUVB,ALL,"ADULT, OLDER_ADULT",NA,"Diala Alshiyab, Irbid, Jordan"
NCT04803461,Catecholamines Level in Vitiligo Patients Before and After Excimer Light,https://clinicaltrials.gov/study/NCT04803461,NO,"Vitiligo, Generalized",DIAGNOSTIC_TEST: serum and urinary catecholamines,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT05238077,Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo,https://clinicaltrials.gov/study/NCT05238077,NO,Generalized Vitiligo,PROCEDURE: Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy,ALL,"ADULT, OLDER_ADULT",NA,"Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit, Michigan, 48202, United States"
NCT03378011,UVA1 Phototherapy in Acral Vitiligo,https://clinicaltrials.gov/study/NCT03378011,NO,Acral Vitiligo,OTHER: phototherapy,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Maha Fathy Elmasry, Cairo, Egypt"
NCT04039451,"Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt",https://clinicaltrials.gov/study/NCT04039451,NO,Psoriasis|Vitiligo,,ALL,"CHILD, ADULT, OLDER_ADULT",,"Assiut University, Assiut, Egypt"
NCT03535051,Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo,https://clinicaltrials.gov/study/NCT03535051,NO,Stable Vitiligo,DEVICE: fractional carbon dioxide laser|DRUG: Tacrolimus Oint 0.03%,ALL,"CHILD, ADULT, OLDER_ADULT",NA,
NCT04818346,A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo,https://clinicaltrials.gov/study/NCT04818346,YES,NonSegmental Vitiligo,DRUG: INCB054707|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Investigative Site 010, Hoover, Alabama, 35244, United States|Investigative Site 015, Gilbert, Arizona, 85295, United States|Investigative Site 028, Scottsdale, Arizona, 85260, United States|Investigative Site 006, Irvine, California, 92697, United States|Investigative Site 009, Los Angeles, California, 90036, United States|Investigative Site 018, Los Angeles, California, 90045, United States|Investigative Site 017, Sacramento, California, 95815, United States|Investigative Site 032, Orange Park, Florida, 32073, United States|Investigative Site 005, Tampa, Florida, 33613, United States|Investigative Site 022, Tampa, Florida, 33614, United States|Investigative Site 011, West Palm Beach, Florida, 33401, United States|Investigative Site 024, Covington, Louisiana, 70433, United States|Investigative Site 002, Brighton, Massachusetts, 02135, United States|Investigative Site 023, Saint Paul, Minnesota, 55112, United States|Investigative Site 027, Verona, New Jersey, 07044, United States|Investigative Site 003, Columbus, Ohio, 43215, United States|Investigative Site 007, Norman, Oklahoma, 73071, United States|Investigative Site 001, Portland, Oregon, 97223, United States|Investigative Site 021, Plymouth Meeting, Pennsylvania, 19462, United States|Investigative Site 004, Murfreesboro, Tennessee, 37130, United States|Investigative Site 033, Dallas, Texas, 75230, United States|Investigative Site 012, San Antonio, Texas, 78213, United States|Investigative Site 030, Spokane, Washington, 99202, United States|Investigative Site 020, Winnipeg, Manitoba, R3M 3Z4, Canada|Investigative Site 014, Etobicoke, Ontario, M8X 1Y9, Canada|Investigative Site 034, London, Ontario, N6H 5LR, Canada|Investigative Site 025, Mississauga, Ontario, L5H 1G9, Canada|Investigative Site 026, North York, Ontario, M2M4J5, Canada|Investigative Site 031, Oakville, Ontario, L6J 7W5, Canada|Investigative Site 008, Peterborough, Ontario, K9J 5K2, Canada|Investigative Site 029, Quebec, Q1V 4X7, Canada"
NCT03358082,Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo,https://clinicaltrials.gov/study/NCT03358082,NO,Vitiligo|Tacrolimus,DRUG: Tacrolimus 0.03% Ointment|DRUG: Hydrocortisone Acetate 1% Ointment,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,"Sohag University, Sohag, Egypt"
NCT03577327,The Gut and Skin Microbiome in Vitiligo Disease Progression,https://clinicaltrials.gov/study/NCT03577327,NO,Vitiligo|Healthy,,ALL,"ADULT, OLDER_ADULT",,"Northwestern University, Chicago, Illinois, 60611, United States"
NCT01701648,Melanocyte Transplantation for Patients With Stable Vitiligo.,https://clinicaltrials.gov/study/NCT01701648,NO,Stable Vitiligo,OTHER: Laser CO2,ALL,ADULT,PHASE1|PHASE2,"University Clinic of Navarre, Pamplona, Navarre, 31008, Spain"
NCT03487042,Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo,https://clinicaltrials.gov/study/NCT03487042,NO,Generalized Vitiligo,DRUG: Bimatoprost 0.03% ophthalmic solution,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,
NCT01202513,Topical Bimatoprost Solution 0.03%in Stable Vitiligo,https://clinicaltrials.gov/study/NCT01202513,NO,Vitiligo|Repigmentation,DRUG: Bimatoprost 0.03% topical ophthalmic solution,ALL,"CHILD, ADULT",PHASE4,
NCT02156427,Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism,https://clinicaltrials.gov/study/NCT02156427,NO,Vitiligo|Piebaldism,DEVICE: VITICELL|DEVICE: PLACEBO,ALL,"ADULT, OLDER_ADULT",PHASE3,"Department of Dermatology - Ghent University Hospital, Ghent, Belgium|University Hospital Center of Bordeaux, Bordeaux, France|CHU Le Mans, Le Mans, France|Dr Michel PASCAL, Paris, France|San Gallicano Dermatological Institute, Roma, Italy"
NCT06072183,A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2,https://clinicaltrials.gov/study/NCT06072183,NO,Stable Nonsegmental Vitiligo|Active Nonsegmental Vitiligo,DRUG: Ritlecitinib|DRUG: Ritlecitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,"Total Dermatology, Birmingham, Alabama, 35203, United States|Total Skin & Beauty Dermatology Center, PC, Birmingham, Alabama, 35205, United States|Center for Dermatology and Plastic Surgery/CCT Research, Scottsdale, Arizona, 85260, United States|Dermatology Trial Associates, Bryant, Arkansas, 72022, United States|First OC Dermatology Research Inc, Fountain Valley, California, 92708, United States|L.A. Universal Research Center, Inc., Los Angeles, California, 90057, United States|Cura Clinical Research - Oxnard, Oxnard, California, 93030, United States|Mission Dermatology Center, Rancho Santa Margarita, California, 92688, United States|Mission Dermatology Center, Rancho Santa Margarita, California, 92688, United States|Peninsula Research Associates, Rolling Hills Estates, California, 90274, United States|University of California San Diego - La Jolla, San Diego, California, 92122, United States|Wolverine Clinical Trials, Santa Ana, California, 92705, United States|Wolverine Clinical Trials, Tustin, California, 92780, United States|Gamma Diagnostic Lab, Doral, Florida, 33172, United States|FXM Clinical Research - Fort Lauderdale, Fort Lauderdale, Florida, 33308, United States|Hear 4 U, Hialeah, Florida, 33015, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|Unlimited Diagnostic Center, Hialeah, Florida, 33016, United States|Wellness Clinical Research, Miami Lakes, Florida, 33016, United States|SouthCoast Research Center, Miami, Florida, 33136, United States|Bio-Medical Research LLC, Miami, Florida, 33144, United States|All Hearing Aid, LLC, Miami, Florida, 33155, United States|Health and Life Research Institute, Miami, Florida, 33155, United States|South Miami Medical & Research Group, Miami, Florida, 33155, United States|New Horizon Research Center, Miami, Florida, 33165, United States|Miami Dermatology and Laser Research, Miami, Florida, 33173, United States|Skin Research of South Florida, Miami, Florida, 33173, United States|Well Pharma Medical Research, Corp., Miami, Florida, 33173, United States|FXM Clinical Research - Miami, Miami, Florida, 33175, United States|JD Medical Group, Miami, Florida, 33176, United States|Floridian Research Institute Llc, Miami, Florida, 33179, United States|Sanitas Research, Miami, Florida, 33186, United States|FXM Clinical Research - Miramar, Miramar, Florida, 33027, United States|GCP Research, Global Clinical professionals, Saint Petersburg, Florida, 33705, United States|NorthShore University Health System, Skokie, Illinois, 60077, United States|The South Bend Clinic, LLC, South Bend, Indiana, 46617, United States|Dermatology & Advanced Aesthetics, Lake Charles, Louisiana, 70605, United States|Concentra Urgent Care, Auburn Hills, Michigan, 48326, United States|Oakland Hills Dermatology, Auburn Hills, Michigan, 48326, United States|Great Lakes Research Group, Inc., Bay City, Michigan, 48706, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202, United States|Great Lakes Hearing Care, Rochester, Michigan, 48307, United States|MediSearch Clinical Trials, Saint Joseph, Missouri, 64506, United States|Canfield Scientific Inc., Parsippany, New Jersey, 07054, United States|Juva Skin & Laser Center, New York, New York, 10022, United States|OptiSkin Medical, New York, New York, 10128, United States|OptiSkin Medical, New York, New York, 10128, United States|DermResearchCenter of New York, Inc., Stony Brook, New York, 11790, United States|Darst Dermatology, Charlotte, North Carolina, 28277, United States|Dermatology Specialists of Charlotte, Charlotte, North Carolina, 28277, United States|Bexley Dermatology Research, Bexley, Ohio, 43209, United States|Centricity Research Dublin Multispeciality, Dublin, Ohio, 43016, United States|Centricity Research Dublin Multispecialty, Dublin, Ohio, 43016, United States|Oregon Dermatology and Research Center, Portland, Oregon, 97210, United States|Columbia Dermatology & Aesthetics, Columbia, South Carolina, 29212, United States|Palmetto Clinical Trial Services - Greenville, Greenville, South Carolina, 29615, United States|International Clinical Research - Tennessee LLC, Murfreesboro, Tennessee, 37130, United States|Center for Clinical Studies, Houston, Texas, 77004, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Austin Institute for Clinical Research, Pflugerville, Texas, 78660, United States|Global Imaging, Sugar Land, Texas, 77478, United States|Complete Dermatology, Sugar Land, Texas, 77479, United States|Fort Bend Hearing, Sugar Land, Texas, 77479, United States|Springville Dermatology - Springville/CCT Research, Springville, Utah, 84663, United States|The Education & Research Foundation, Inc., Lynchburg, Virginia, 24501, United States|Virginia Dermatology and Skin Cancer Center, Norfolk, Virginia, 23502, United States|Diagnostic - Consultative Center XXVIII - Sofia, Sofia, 1528, Bulgaria|""Diagnostic - Consultative Center XX - Sofia"" EOOD, Sofia, 1618, Bulgaria|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|SimcoDerm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|DermEffects, London, Ontario, N6H 5L5, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|Medicor Research Inc, Sudbury, Ontario, P3C 1X3, Canada|Sudbury Skin Clinique, Sudbury, Ontario, P3C 1X8, Canada|North York Research Inc, Toronto, Ontario, M2N 3A6, Canada|Dermatology on Bloor - Research Toronto, Toronto, Ontario, M4W 2N4, Canada|Innovaderm Research Inc., Montréal, Quebec, H2X 2V1, Canada|Centre de Recherche Saint-Louis, Sherbrooke, Quebec, J1G 1X9, Canada|Diex Recherche sherbrooke Inc., Sherbrooke, Quebec, J1L 0H8, Canada|Skinsense Medical Research, Saskatoon, Saskatchewan, S7K 2C1, Canada|Diex Recherche Quebec Inc., Quebec, G1V 4T3, Canada|Alpha Recherche Clinique, Quebec, G2J 0C4, Canada|Beijing Friendship Hospital Affiliate of Capital University, Beijing, Beijing, 100050, China|Peking Union Medical College Hopital, Beijing, Beijing, 100730, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|The First Affiliated Hospital Of Fujian Medical University, Fuzhou, Fujian, 350005, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Guangzhou First People's Hospital, Guangzhou, Guangdong, 510180, China|The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China|The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China|The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050030, China|NanYang First people's hospital, Nanyang, Henan, 473000, China|The First Hospital of Wuhan, Wuhan, Hubei, 430022, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|The First Affiliated Hospital of Baotou Medical College, Baotou, Inner Mongolia, 014010, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China|Huashan Hospital, Fudan University, Shanghai, Shanghai, 200040, China|Chengdu second people's hospital, Chengdu, Sichuan, 610017, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Sheng, 650032, China|Hangzhou Third Hospital, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|The First Affiliated Hospital Of Fujian Medical University, Fuzhou, 350005, China|Shanghai General Hospital, Shanghai, 200080, China|The First Hospital of Hebei Medical University, Shijiazhuang, 050030, China|Hautzentrum im Jahrhunderthaus, Bochum, Nordrhein-westfalen, 44793, Germany|BAG Drs. Med. Quist PartG, Mainz, Rheinland-pfalz, 55128, Germany|HNO-Praxis Dr. Kugler in Magdeburg, Magdeburg, Sachsen-anhalt, 39104, Germany|Magdeburger Company for Medical Studies and Services, Magdeburg, Sachsen-anhalt, 39104, Germany|Radiologie Ulrichshaus, Magdeburg, Sachsen-anhalt, 39104, Germany|Pécsi Tudományegyetem Klinikai Központ, Pécs, Baranya, 7632, Hungary|Synexus Magyarorszag Kft. (Gyula DRS), Gyula, Békés, 5700, Hungary|Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ, Szeged, Csongrád, 6720, Hungary|Allergo-Derm Bakos Kft, Szolnok, Jász-nagykun-szolnok, 5000, Hungary|Óbudai Egészségügyi Centrum, Budapest, 1036, Hungary|Orvostudomanyi Kutato es Fejleszto Kft, Debrecen, 4027, Hungary|DERMA-B Egészségügyi és Szolgáltató, Debrecen, 4031, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Derm-Surg Kft., Kaposvár, 7400, Hungary|Istituto Dermopatico Immacolata, Rome, Roma, 00167, Italy|Japan Community Health Care Organization Chukyo Hospital, Nagoya, Aichi, 457-8510, Japan|Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Aichi, 457-8510, Japan|Toho University Sakura Medical Center, Sakura, Chiba, 285-8741, Japan|Juntendo University Urayasu Hospital, Urayasu, Chiba, 279-0021, Japan|Takarazuka City Hospital, Takarazuka, Hyōgo, 665-0827, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki-gun, Ibaraki, 300-0395, Japan|Tokyo Medical University Ibaraki Medical Center, Inashiki, Ibaraki, 300-0395, Japan|Kindai University Nara Hospital, Ikoma City, Nara, 630-0293, Japan|Osaka Habikino Medical Center, Habikino, Osaka, 583-8588, Japan|Hamamatsu University Hospital, Hamamatsu-shi, Shizuoka, 431-3192, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Tokyo Medical And Dental University Hospital, Bunkyō, Tokyo, 113-8519, Japan|Yamaguchi University Hospital, Ube, Yamaguchi, 755-8505, Japan|Wromedica I Bielicka A Strzalkowska s.c., Wroclaw, Dolnośląskie, 51-685, Poland|Clinica Dermatoestetica Prywatny Gabinet Dermatologiczny I Alergologiczny Prof.Dr Hab.Med. Barbara Z, Bydgoszcz, Kujawsko-pomorskie, 85-650, Poland|ETG Warszawa, Warszawa, Mazowieckie, 02-677, Poland|Klinika Ambroziak Dermatologia, Warszawa, Mazowieckie, 02-953, Poland|Carpe Diem Centrum Medycyny Estetycznej, Warszaw, Mazowieckie, 02-661, Poland|Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Marek Brzewski, Paweł Brzewski spółka, Kraków, Małopolskie, 30-002, Poland|Specderm Poznanska sp.j., Bialystok, Podlaskie, 15-375, Poland|ClinicMed Daniluk, Nowak Spółka komandytowa, Bialystok, Podlaskie, 15-879, Poland|""DERMED"" Centrum Medyczne Sp. z o.o., Lodz, Łódzkie, 90-265, Poland|Clinmedica Research Sp. z. o. o., Skierniewice, Łódzkie, 96-100, Poland|Centrum Medyczne Angelius Provita, Katowice, Śląskie, 40-611, Poland|Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Banskobystrický KRAJ, 97517, Slovakia|SANARE, s.r.o, Svidnik, Prešovský KRAJ, 089 01, Slovakia|Fakultna nemocnica Trnava, Trnava, Trnavský KRAJ, 917 75, Slovakia|CLINIQ s.r.o., Bratislava, 811 09, Slovakia|BeneDerma, Bratislava, 841 02, Slovakia|Derma therapy spol. s.r.o., Bratislava, 851 01, Slovakia|Topskin pro s.r.o., Kosice, 040 01, Slovakia|Poliklinika ProCare Kosice s.r.o., Kosice, 040 23, Slovakia|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [cataluña], 08041, Spain|Hospital Universitario Infanta Leonor, Madrid, Madrid, Comunidad DE, 28031, Spain|Clinica Universidad de Navarra, Madrid, 28027, Spain|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitari i Politecnic La Fe, València, 46026, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan"
NCT05583526,A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo,https://clinicaltrials.gov/study/NCT05583526,NO,Stable Nonsegmental Vitiligo|Active Nonsegmental Vitiligo,DRUG: Ritlecitinib|DRUG: Placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham Faculty Office Towers (Regulatory, Birmingham, Alabama, 35294, United States|California Dermatology & Clinical Research Institute, Encinitas, California, 92024, United States|Center For Dermatology Clinical Research, Inc., Fremont, California, 94538, United States|Marvel Clinical Research, Huntington Beach, California, 92647, United States|Wallace Medical Group, Inc, Los Angeles, California, 90056, United States|Audiology, Washington, District of Columbia, 20007, United States|MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|Center for Dermatology and Dermatologic Surgery, Washington, District of Columbia, 20037, United States|Encore Medical Research of Boynton Beach, Boynton Beach, Florida, 33436, United States|Skin Care Research, Hollywood, Florida, 33021, United States|JC Audiology, Lutz, Florida, 33548, United States|Millennium Clinical Research, Miami, Florida, 33125, United States|Clever Medical Research, Miami, Florida, 33126, United States|Tory Sullivan, MD PA, North Miami Beach, Florida, 33162, United States|Tory Sullivan, Md Pa, North Miami Beach, Florida, 33162, United States|Ziaderm Research, LLC, North Miami Beach, Florida, 33162, United States|Olympian Clinical Research, Saint Petersburg, Florida, 33709, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Tower Imaging, LLC dba TGH Imaging powered by Tower, Tampa, Florida, 33618, United States|Marietta Dermatology Clinical Research, Inc, Marietta, Georgia, 30060, United States|Advanced Medical Research, PC., Sandy Springs, Georgia, 30328, United States|Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, 46250, United States|Velocity Clinical Research at The Dermatology Clinic, Baton Rouge, Baton Rouge, Louisiana, 70808, United States|DelRicht Research, Baton Rouge, Louisiana, 70809, United States|The NeuroMedical Center (XRay), Baton Rouge, Louisiana, 70810, United States|DelRicht Research, New Orleans, Louisiana, 70115, United States|Prairieville Family Hospital (XRay), Prairieville, Louisiana, 70769, United States|Callender Center for Clinical Research, Glenn Dale, Maryland, 20769, United States|Visage Dermatology and Aesthetic Center, Largo, Maryland, 20774, United States|Lawrence J Green, MD LLC, Rockville, Maryland, 20850, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|MetroBoston Clinical Partners, LLC, Brighton, Massachusetts, 02135, United States|University of Massachusetts Chan Medical School, Worcester, Massachusetts, 01655, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Hamzavi Dermatology - Canton, Canton, Michigan, 48187, United States|Skin Specialists, PC, Omaha, Nebraska, 68144, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, 87102, United States|SUNY Downstate Health Sciences University, Brooklyn, New York, 11203, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|University of North Carolina Medical Center, Chapel Hill, North Carolina, 27516, United States|Clinical & Translational Research Center (CTRC), Chapel Hill, North Carolina, 27599, United States|Accellacare - Wilmington, Wilmington, North Carolina, 28411, United States|Accellacare, Wilmington, North Carolina, 28411, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28411, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Remington Davis Clinical Research, Columbus, Ohio, 43215, United States|Remington-Davis, Inc, Columbus, Ohio, 43215, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Bellaire Dermatology Associates, Bellaire, Texas, 77401, United States|Modern Research Associates, PLLC, Dallas, Texas, 75231, United States|Alpesh D. Desai, DO PLLC - Research, Houston, Texas, 77008, United States|Alpesh D. Desai, DO PLLC, Houston, Texas, 77008, United States|Austin Institute for Clinical Research, Houston, Texas, 77056, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Texas Dermatology and Laser Specialists, San Antonio, Texas, 78218, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|The Skin Hospital, Darlinghurst, New South Wales, 2010, Australia|North Eastern Health Specialists, Campbelltown, South Australia, 5074, Australia|Skin Health Institute Inc., Carlton, Victoria, 3053, Australia|Dr Rodney Sinclair Pty Ltd, East Melbourne, Victoria, 3002, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|MC ""Asklepiy"" OOD, Dupnitsa, 2600, Bulgaria|DCC Aleksandrovska EOOD, Sofia, 1431, Bulgaria|UMHAT ""Prof. dr. Stoyan Kirkovich"" AD, Stara Zagora, 6000, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|CARe Clinic, Red Deer, Alberta, T4P 1K4, Canada|SKiN Health, Cobourg, Ontario, K9A 0Z4, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L4Y 4C5, Canada|Oshawa Clinic Dermatology Trials, Oshawa, Ontario, L1H 1B9, Canada|North York Research Inc, Toronto, Ontario, M2N3A6, Canada|Centre de Recherche Dermatologique du Quebec metropolitain, Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Fujian Medical University Affiliated First Hospital, Fuzhou, Fujian, 350005, China|Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, 510091, China|Guangzhou First People's Hospital, Guangzhou, Guangdong, 510180, China|The First Hospital of Wuhan, Wuhan, Hubei, 430022, China|The First Hospital of China Medical University/Dermatology and STD Department, Shenyang, Liaoning, 110001, China|Huashan Hospital Fudan University, Shanghai, Shanghai, 200040, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300052, China|First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Sheng, 650032, China|Zhejiang Provincial People's Hospital/Dermatology Department, Hangzhou, Zhejiang, 310014, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China|The first Affiliated hospital of Wenzhou medical University, Wenzhou, Zhejiang, 325000, China|The first Affiliated hospital of Wenzhou medical University, Wenzhou, Zhejiang, 325000, China|Praxis Leitz und Kollegen, Stuttgart, Baden-württemberg, 70178, Germany|Universitaetsklinikum Erlangen, Erlangen, Bayern, 91054, Germany|Fachklinik Bad Bentheim, Bad Bentheim, Niedersachsen, 48455, Germany|Universitätsklinikum Münster, Münster, Nordrhein-westfalen, 48149, Germany|Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma, Lazio, 00168, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Lombardia, 25123, Italy|Istituto Clinico Humanitas IRCCS, Rozzano, Milano, 20089, Italy|Istituto Clinico Humanitas IRCSS - UOC di Dermatologia, Rozzano, Milano, 20089, Italy|Istituto Clinico Humanitas, IRCCS, Rozzano, Milano, 20089, Italy|Istituti Fisioterapici Ospitalieri (IFO) - Roma, Roma, RM, 00144, Italy|Istituti Fisioterapici Ospitalieri (IFO), Roma, RM, 00144, Italy|Policlinico S. Orsola- Malpighi, Bologna, 40138, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, 25123, Italy|Nagoya City University Hospital, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai-shi, Miyagi, 980-8574, Japan|Dermatology and Ophthalmology Kume Clinic, Sakai City, Osaka, 593-8324, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Sugamo Kobayashi Derma Clinic, Toshima-Ku, Tokyo, 170-0002, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Dongguk University Ilsan Hospital, Goyang-si, Kyǒnggi-do, 10326, Korea, Republic of|The Catholic University Of Korea St. Vincent's Hospital, Suwon-si, Kyǒnggi-do, 16247, Korea, Republic of|Ajou University Hospital, Suwon, Kyǒnggi-do, 16499, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [seoul], 03722, Korea, Republic of|Hospital Infantil de Mexico Federico Gomez, Mexico City, Distrito Federal, 06720, Mexico|Centro de Dermatologia de Monterrey, Monterrey, Nuevo LEÓN, 64460, Mexico|Sociedad de Metabolismo y Corazon S.C., Veracruz, 91900, Mexico|Sociedad de Metabolismo Y Corazon Sc, Veracruz, 91900, Mexico|Arké SMO S.A de C.V, Veracruz, 91910, Mexico|DermoDent Centrum Medyczne Aldona Czajkowska Rafał Czajkowski s.c., Osielsko, Kujawsko-pomorskie, 86-031, Poland|Royalderm Agnieszka Nawrocka, Warszawa, Mazowieckie, 02-962, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Twoja Przychodnia SCM, Szczecin, Zachodniopomorskie, 71-500, Poland|Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak, Lodz, Łódzkie, 90-436, Poland|Dermedic Jacek Zdybski, Ostrowiec Witokrzyski, Świętokrzyskie, 27-400, Poland|Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern CAPE, 5099, South Africa|Phoenix Pharma, Port Elizabeth, Eastern CAPE, 6001, South Africa|Clinresco Centres, Kempton Park, Gauteng, 1619, South Africa|Botho Ke Bontle Health Services, Pretoria, Gauteng, 0184, South Africa|Task Central, Cape Town, Western CAPE, 7530, South Africa|Hospital Universitario Reina Sofia, Cordoba, Andalucía, 14004, Spain|Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Canarias, 35010, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|AUDIKA, Córdoba, 14001, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Istanbul Universitesi- Cerrahpasa, Cerrahpasa Tip Fakultesi, Istanbul, 34098, Turkey|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, 34890, Turkey|Erciyes Universitesi Tıp Fakultesi Hastaneleri, Kayseri, 38039, Turkey|Celal Bayar Universitesi Hafta Sultan Hastanesi, Manisa, 45030, Turkey|Guy's & St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom"
NCT01377077,Punchgrafting Techniques for Vitiligo,https://clinicaltrials.gov/study/NCT01377077,NO,Non-segmental Vitiligo|Segmental Vitiligo|Piebaldism,PROCEDURE: punchgrafting|PROCEDURE: punchgrafting,ALL,"ADULT, OLDER_ADULT",PHASE4,"Netherlands Institute for Pigmentdisorders, Amsterdam, Noord-Holland, 1105 AZ, Netherlands"
NCT05335746,Ocular Changes in Vitiligo Patients on Therapy,https://clinicaltrials.gov/study/NCT05335746,NO,Vitiligo|Chorioretinopathy|Chorioretinitis,DIAGNOSTIC_TEST: Optical coherence tomography angiography (OCT-A),ALL,"ADULT, OLDER_ADULT",,"Benha University, Banhā, QA, 13511, Egypt"
NCT00509314,The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis,https://clinicaltrials.gov/study/NCT00509314,NO,Melanocyte|Vitiligo,BEHAVIORAL: melanocyte self-assembly and functional analysis,ALL,ADULT,,"National Taiwan University Hospital, Taipei, 100, Taiwan"
NCT04057573,Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2),https://clinicaltrials.gov/study/NCT04057573,YES,Non-segmental Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Desert Sky Dermatology, Gilbert, Arizona, 85295, United States|Center For Dermatology Cosmetic and Laser Surgery, Fremont, California, 94538, United States|Uci Beckman Laser Institute and Medical Clinic, Irvine, California, 92617, United States|UCI Health Beckman Laser Institute and Medical Center, Irvine, California, 92697, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Dermatology Research Associates, Los Angeles, California, 90045, United States|Dermatology Specialists Inc, Murrieta, California, 92562, United States|Dermatology Specialists Inc, Oceanside, California, 92056, United States|Integrative Skin Science and Research, Sacramento, California, 95815, United States|Acrc Studies, San Diego, California, 92119, United States|Central Sooner Research, San Diego, California, 92123, United States|Colorado Medical Research Center Inc, Denver, Colorado, 80210, United States|Advanced Pharma Cr, Miami, Florida, 33147, United States|Leavitt Medical Associates of Florida, Ormond Beach, Florida, 32174, United States|Avita Clinical Research, Tampa, Florida, 33613, United States|Olympian Clinical Research, Tampa, Florida, 33614, United States|Ashira Dermatology Llc, Gurnee, Illinois, 60031, United States|Randall Dermatology of West Lafayette, West Lafayette, Indiana, 47096, United States|Randall Dermatology, West Lafayette, Indiana, 47906, United States|Delricht Clinical Research - Clinedge - Ppds Baton Rouge, Baton Rouge, Louisiana, 70809, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Tufts Medical Center, Boston, Massachusetts, 02116, United States|Metro Boston Clinical Partners, Brighton, Massachusetts, 02135, United States|University of Massachusetts, Worcester, Massachusetts, 01655, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Minnesota Clinical Study Center, Minneapolis, Minnesota, 55432, United States|Jdr Dermatology Research, Las Vegas, Nevada, 89148, United States|Northwell Physician Partners, New Hyde Park, New York, 11042, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Derm Research Center of New York Inc, Stony Brook, New York, 11790, United States|Central Sooner Research, Norman, Oklahoma, 73071, United States|Oregon Medical Research Center, Portland, Oregon, 97223, United States|Clinical Research Partners Llc, Richmond, Virginia, 23220, United States|Medical Center Unimed Eood, Sevlievo, 05400, Bulgaria|Medical Center Unimed EOOD, Sevlievo, 5300, Bulgaria|Diagnostic Consultative Center Ii Sofia Eood, Sofia, 01000, Bulgaria|University Multiprofile Hospital For Active Treatment Aleksandrovska, Sofia, 01431, Bulgaria|Diagnostic Consultative Center II Sofia EOOD, Sofia, 1000, Bulgaria|Diagnostic Consultative Center II Sofia EOOD, Sofia, 1407, Bulgaria|University Hospital Prof Dr Stoyan Kirkovich, Stara Zagora, 06003, Bulgaria|University Hospital "" Prof. Dr Stoyan Kirkovich"", Stara Zagora, 6003, Bulgaria|Simcoderm Medical and Surgical Dermatology Center, Barrie, Ontario, L4M 7G1, Canada|Kingsway Clinical Research, Etobicoke, Ontario, M8X 1Y9, Canada|Lynderm Research Inc, Markham, Ontario, L3P 1X2, Canada|K. Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Xlr8 Medical Research, Windsor, Ontario, N8W 1E6, Canada|Centre Hospitalier Universitaire de Besancon, Besancon, 25000, France|CHU Besancon, Besancon, 25030, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, 33000, France|CHU de Bordeaux, Hospital Saint Andre, Bordeaux, 33075, France|University Hospital Henri Mondor, Creteil, 94000, France|CENTRE HOSpITALIER UNIVERSITAIRE HENRI MONDOR, Creteil, 94010, France|Le Bateau Blanc, Martigues, 13500, France|Emovis GMBH, Berlin, 10629, Germany|Universitatsklinikum Bonn Aoer, Bonn, 53127, Germany|Hautarztpraxis Mahlow, Mahlow, 15831, Germany|Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, 55131, Germany|University Medical Center (Universitätsmedizin der Johannes Gutenberg-Universität Mainz), Mainz, 55131, Germany|Policlinico S. Orsola Malpighi, Bologna, 40138, Italy|Istituto Dermatologico San Gallicano, Rome, 00163, Italy|Amsterdam University Medical Centre, Amsterdam, 1105 AZ, Netherlands|Synexus Polska Sp. Z o.o. Oddział w Częstochowie, Czestochowa, 42-202, Poland|Synexus Affiliate - Krakowskie Centrum Medyczne, Krakow, 31-501, Poland|Synexus Polska Sp Z Oo Oddzial W Lodzi, Lodz, 90-127, Poland|Synexus Polska Sp Z Oo Oddzial W Czestochowie, Lublin, 20-081, Poland|Lubeskie Centrum Diagnostyczne, Swidnik, 21-040, Poland|High-Med Przychodnia Specjalistycza, Warsaw, 01-817, Poland|Synexus Polska Sp. Z O.O. Oddzial Warszawie, Warszawa, 01-192, Poland|Dermmedica Sp. Z O.O., Wroclaw, 51-318, Poland|Ico Hospital Germans Trias I Pujol, Badalona, 08916, Spain|Hospital Universitari Germans Trias i Pujol, Barcelona, 8916, Spain|Dermomedic, Madrid, 28001, Spain|IDEI (Instituto de Dermatología Integral)., Madrid, 28010, Spain|Hospital La Paz (Hospital Universitario La Paz ), Madrid, 28046, Spain|Hospital Universitario de La Paz, Madrid, 28046, Spain"
NCT04052425,Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1),https://clinicaltrials.gov/study/NCT04052425,YES,Non-segmental Vitiligo,DRUG: Ruxolitinib cream|DRUG: Vehicle,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,"Cahaba Dermatology, Hoover, Alabama, 35244, United States|Cognitive Clinical Trials Scottsdale Btc Ppds, Scottsdale, Arizona, 85260, United States|Burke Pharmaceutical Research, Hot Springs National Park, Arkansas, 71913, United States|First Oc Dermatology, Fountain Valley, California, 92708, United States|Marvel Clinical Research Llc, Huntington Beach, California, 92647, United States|Rady Children'S Hospital - San Diego, San Diego, California, 92123, United States|University of California San Francisco Sub Location, San Francisco, California, 94158, United States|Clinical Research Center of Ct, Danbury, Connecticut, 06810, United States|Harmony Medical Research Institute, Hialeah, Florida, 33016, United States|San Marcus Research Clinic Inc., Miami Lakes, Florida, 33014, United States|ForCare Medical Center, Tampa, Florida, 33613, United States|Forcare Clinical Research Fcr Forward Clinical Trials, Inc, Tampa, Florida, 33624, United States|Metabolic Research Institute Inc, West Palm Beach, Florida, 33401, United States|Northwestern University, Chicago, Illinois, 60611, United States|Clinical Trials Management Llc, Metairie, Louisiana, 70006, United States|Great Lakes Research Group Inc, Bay City, Michigan, 48706, United States|Dermatology Specialists of Brighton, Brighton, Michigan, 48114, United States|Suny Downstate Medical Center, Brooklyn, New York, 11203, United States|Forest Hills Dermatology Group, Forest Hills, New York, 11375, United States|The Dermatology Specialists Greenwich, New York, New York, 10012, United States|Wake Research Associates Llc, Raleigh, North Carolina, 27612, United States|Wake Forest University, Winston-Salem, North Carolina, 27157, United States|Kgl Skin Study Center, Broomall, Pennsylvania, 19008, United States|Dermatology Associates of Plymouth Meeting, Plymouth Meeting, Pennsylvania, 19462, United States|Palmetto Clinical Trial Services, Anderson, South Carolina, 29621, United States|International Clinical Research Tennessee Llc, Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research, San Antonio, Texas, 78213, United States|Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, 78229, United States|Dermatology Specialists of Spokane, Spokane, Washington, 99202, United States|Multiprofile Hospital For Active Treatement - Clinic of Dermatology and Venerology, Pleven, 05800, Bulgaria|DCC 28, Sofia, 01592, Bulgaria|Medical Center Eurohealth, Sofia, 01606, Bulgaria|Dermatology Research Institute, Calgary, Alberta, T1Y 0B4, Canada|Institute For Skin Advancement, Calgary, Alberta, T3A 2N1, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Windsor Clinical Research Inc, Windsor, Ontario, N8W 5L7, Canada|McGill University Health Centre / Carey/Wang Clinic, Montreal, Quebec, H3Z2S6, Canada|Siena Medical Reserch Corporation, Westmount, Quebec, H3Z 2S6, Canada|Centre Hospitalier Universitaire de Nantes, Nantes, 44000, France|Chu de Nice - Hopital L'Archet 1, Nice Cedex 3, 06202, France|Hopital Charles Nicolle Chu Rouen - Hopital de Bois-Guillaume, Rouen, 76031, France|Chu de Toulouse Hopital Larrey Centre de Reference Des Maladies Rares de La Peau Service de Dermatol, Toulouse, 31059, France|University Clinic Carl Gustav Carus, Technical University Dresden, Dresden, 01307, Germany|Universitatsklinik Munster Dermatologie, Muenster, 48149, Germany|Presidio Ospedaliero Piero Palagi, Firenze, 50125, Italy|Istituto Dermatologico San Gallicano, Rome, 00144, Italy|Synexus - Polska Sp Z Oo Oddzial W Gdansk, Gdansk, 80-382, Poland|Synexus Polska Sp. Z O.O. Oddzial W Gdyni, Gdynia, 81-537, Poland|Synexus - Sp Z Oo Oddzial W Katowice, Katowice, 40-040, Poland|Dermedic Dr. Zdybski, Ostrowiec, 27-400, Poland|Synexus Polska Sp. Z O.O. Oddzial W Poznaniu, Poznan, 60-702, Poland|Poradnia Dermatologiczno-Wenerologiczna Mediderm S.C. Nzoz, Torun, 87-100, Poland|Synexus Polska Sp. Z O.O. Oddzial We Wroclawiu, Wroclaw, 50-381, Poland|Hospital Cima Sanitas, Barcelona, 08034, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario San Cecilio, Granada, 18016, Spain|Clinica Universidad de Navarra (Cun), Pamplona, 31008, Spain"
NCT06218082,Vitiligo Registry for Adults and Children in the UK,https://clinicaltrials.gov/study/NCT06218082,NO,Dermatologic Disease|Vitiligo,,ALL,"CHILD, ADULT, OLDER_ADULT",,"The Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, United Kingdom"
NCT05990309,ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO,https://clinicaltrials.gov/study/NCT05990309,NO,Non-segmental Vitiligo,DIAGNOSTIC_TEST: skin biopsy,ALL,"ADULT, OLDER_ADULT",NA,
NCT04927975,Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo,https://clinicaltrials.gov/study/NCT04927975,NO,Non-Segmental Vitiligo,DRUG: Upadacitinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"University of California Irvine /ID# 229390, Irvine, California, 92697-1385, United States|Stanford University /ID# 228000, Redwood City, California, 94063, United States|Clearlyderm Dermatology /ID# 227993, Boca Raton, Florida, 33428, United States|New Horizon Research Center /ID# 229403, Miami, Florida, 33165-3372, United States|Park Avenue Dermatology, PA /ID# 229400, Orange Park, Florida, 32073, United States|ForCare Clinical Research /ID# 228010, Tampa, Florida, 33613-1244, United States|Dawes Fretzin, LLC /ID# 227996, Indianapolis, Indiana, 46256, United States|Tufts Medical Center /ID# 228087, Boston, Massachusetts, 02111-1552, United States|UMass Chan Medical School /ID# 228066, Worcester, Massachusetts, 01655, United States|Michigan Center for Research Company /ID# 228054, Clarkston, Michigan, 48346, United States|Hamzavi Dermatology /ID# 228056, Fort Gratiot, Michigan, 48059, United States|Remington-Davis Clinical Research /ID# 229401, Columbus, Ohio, 43215, United States|Essential Medical Research, LLC /ID# 228074, Tulsa, Oklahoma, 74137-2842, United States|Oregon Dermatology and Research Center /ID# 228007, Portland, Oregon, 97210, United States|Oregon Medical Res Center PC /ID# 228073, Portland, Oregon, 97223, United States|Medical University of South Carolina /ID# 228067, Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC /ID# 228059, Murfreesboro, Tennessee, 37130-2450, United States|Bellaire Dermatology Associates /ID# 228004, Bellaire, Texas, 77401, United States|University of Texas Health Science Center at Houston /ID# 229399, Houston, Texas, 77030-1501, United States|Virginia Clinical Research, Inc. /ID# 228050, Norfolk, Virginia, 23507, United States|Dr. Chih-ho Hong Medical Inc. /ID# 228403, Surrey, British Columbia, V3R 6A7, Canada|Wiseman Dermatology Research /ID# 228410, Winnipeg, Manitoba, R3M 3Z4, Canada|Research Toronto /ID# 228401, Toronto, Ontario, M4W 2N4, Canada|K. Papp Clinical Research /ID# 228877, Waterloo, Ontario, N2J 1C4, Canada|Centre de Recherche dermatologique du Quebec Metropolitain /ID# 228388, Québec, Quebec, G1V 4X7, Canada|Chu de Nice-Hopital L'Archet Ii /Id# 228192, Nice, Alpes-Maritimes, 06200, France|Hopital Saint-Andre /ID# 228193, Bordeaux, Gironde, 33075, France|HCL - Hopital Edouard Herriot /ID# 228194, Lyon, Rhone, 69003, France|Hopital Henri Mondor /ID# 228198, Creteil, 94000, France|CHU Toulouse - Hopital Larrey /ID# 228196, Toulouse, 31400, France|Nagoya City University Hospital /ID# 228725, Nagoya shi, Aichi, 467-8602, Japan|Nippon Medical School Hospital /ID# 230361, Bunkyo-ku, Tokyo, 113-8602, Japan|Tokyo Medical University Hospital /ID# 230288, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamagata University Hospital /ID# 230362, Yamagata-shi, Yamagata, 990-9585, Japan|Yamanashi Prefectural Central Hospital /ID# 229441, Kofu-shi, Yamanashi, 400-8506, Japan"
NCT06113328,A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007),https://clinicaltrials.gov/study/NCT06113328,NO,Non-segmental Vitiligo,BIOLOGICAL: MK-6194|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Cahaba Dermatology & Skin Health Center ( Site 0127), Birmingham, Alabama, 35244, United States|Burke Pharmaceutical Research ( Site 0124), Hot Springs, Arkansas, 71913, United States|The Vitiligo & Pigmentation Institute of Southern California ( Site 0115), Los Angeles, California, 90036, United States|Indiana University Health University Hospital-Indiana University School of Medicine, Department of (, Indianapolis, Indiana, 46202, United States|Dawes Fretzin Clinical Research Group, LLC ( Site 0106), Indianapolis, Indiana, 46250, United States|Metro Boston Clinical Partners ( Site 0110), Brighton, Massachusetts, 02135, United States|Hamzavi Dermatology - Canton ( Site 0101), Canton, Michigan, 48187, United States|Remington Davis Clinical Research-Outpatient ( Site 0104), Columbus, Ohio, 43215, United States|Medical University of South Carolina-Dermatology Research ( Site 0114), Charleston, South Carolina, 29425, United States|International Clinical Research - Tennessee LLC ( Site 0120), Murfreesboro, Tennessee, 37130, United States|Progressive Clinical Research ( Site 0108), San Antonio, Texas, 78213, United States|Virginia Clinical Research, Inc. ( Site 0109), Norfolk, Virginia, 23502, United States|Dermatology Specialists of Spokane ( Site 0126), Spokane, Washington, 99202, United States|Psoriahue ( Site 0205), Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425DKG, Argentina|Stat Research S.A. ( Site 0204), Buenos Aires, Caba, C1023AAB, Argentina|Centro de Investigaciones Metabólicas (CINME)-Dermatology ( Site 0203), Ciudad Autónoma de Buenos Aires, Caba, C1027AAP, Argentina|Instituto Medico Strusberg ( Site 0208), Córdoba, Cordoba, X5000EDC, Argentina|Hospital Aleman-Dermatologia ( Site 0209), Buenos Aires, C1118AAT, Argentina|Paratus Clinical Research Woden ( Site 1703), Phillip, Australian Capital Territory, 2606, Australia|Westmead Hospital-Dermatology ( Site 1701), Westmead, New South Wales, 2145, Australia|Skin Health Institute Inc.-Trials ( Site 1702), Carlton, Victoria, 3053, Australia|Sinclair Dermatology ( Site 1704), Melbourne, Victoria, 3002, Australia|UZ Gent ( Site 0604), Gent, Oost-Vlaanderen, 9000, Belgium|Enverus Medical Research ( Site 0006), Surrey, British Columbia, V3V 0C6, Canada|Diex Recherche sherbrooke Inc. ( Site 0007), Sherbrooke, Quebec, J1L 0H8, Canada|Diex Recherche Quebec Inc. ( Site 0008), Quebec, G1V 4T3, Canada|Centre de Recherche Dermatologique du Quebec metropolitain ( Site 0002), Quebec, G1V 4X7, Canada|Dermisur ( Site 0305), Osorno, Los Lagos, 5310644, Chile|Clinical Research Chile SpA ( Site 0304), Valdivia, Los Rios, 5110683, Chile|Clinica Dermacross ( Site 0301), Santiago, Region M. De Santiago, 7640881, Chile|Pontificia Universidad Catolica de Chile-CICUC ( Site 0308), Santiago, Region M. De Santiago, 8330034, Chile|Centro Internacional de Estudios Clinicos (CIEC) ( Site 0302), Santiago, Region M. De Santiago, 8420383, Chile|Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 0803), Nice, Alpes-Maritimes, 06202, France|CHU de Bordeaux Hop St ANDRE ( Site 0804), Bordeaux, Aquitaine, 33075, France|Hôpital Edouard Herriot ( Site 0802), Lyon, Rhone-Alpes, 69003, France|HENRI MONDOR HOSPITAL ( Site 0801), Créteil, Val-de-Marne, 94000, France|Universitaetsklinikum Erlangen-Hautklinik Studienambulanz ( Site 0905), Erlangen, Bayern, 91054, Germany|Universitätsklinikum Münster-Hautklinik ( Site 0904), Münster, Nordrhein-Westfalen, 48149, Germany|Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0901), Berlin, 10117, Germany|Rambam Health Care Campus-Dermatology ( Site 1002), Haifa, 3109601, Israel|Sheba Medical Center-Dermatology ( Site 1001), Ramat Gan, 5265601, Israel|Nagoya City University Hospital-Dermatology ( Site 2002), Nagoya, Aichi, 467-8602, Japan|Osaka University Hospital ( Site 2004), Suita, Osaka, 565-0871, Japan|Tokyo Medical University Hospital ( Site 2001), Shinjuku-ku, Tokyo, 160-0023, Japan|Inha University Hospital ( Site 1992), Incheon, 22332, Korea, Republic of|Seoul National University Hospital-Dermatology ( Site 1991), Seoul, 03080, Korea, Republic of|Severance Hospital, Yonsei University Health System-Department of Dermatology ( Site 1993), Seoul, 03722, Korea, Republic of|Amsterdam UMC, locatie AMC-Dermatology ( Site 1101), Amsterdam, Noord-Holland, 1105 AZ, Netherlands|Hospital Universitario Puerta del Mar ( Site 1302), Cádiz, Andalucia, 11009, Spain|Hospital Universitari de Bellvitge-Dermatology ( Site 1307), L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Clinica Universidad de Navarra ( Site 1305), Madrid, Madrid, Comunidad De, 28027, Spain|Cantonal Hospital St.Gallen ( Site 1402), st.Gallen, Sankt Gallen, 9007, Switzerland|New Cross Hospital ( Site 1601), Wolverhampton, WV10 0QP, United Kingdom"
NCT04811326,Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation,https://clinicaltrials.gov/study/NCT04811326,NO,Non-segmental Vitiligo,RADIATION: NB-UVB|DRUG: Latanoprost,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"faculty of medicine, Aswan University, Aswan, Aswan Governorate, 81528, Egypt"
NCT04942860,The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT04942860,NO,Non-segmental Vitiligo,DRUG: 1% Methotrexate gel|DRUG: 0.5% Methotrexate gel,ALL,"ADULT, OLDER_ADULT",PHASE3,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland"
NCT04920162,Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma,https://clinicaltrials.gov/study/NCT04920162,NO,Melanoma and Vitiligo,OTHER: Biospecimen into patients who had skin diseases,ALL,"ADULT, OLDER_ADULT",NA,"CHU de Nice, Nice, Provence Alpes Cote d'Azur, 06000, France"
NCT03047733,Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT03047733,NO,Dermatologic Disease|Vitiligo,DEVICE: The XTRAC Excimer Laser System|DRUG: Topical tacrolimus 0.1% ointment,ALL,"CHILD, ADULT, OLDER_ADULT",NA,"Ajou university hospital, Suwon-si, Gyeonggi-do, 16499, Korea, Republic of"
NCT04487860,Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo,https://clinicaltrials.gov/study/NCT04487860,NO,Non-segmental Vitiligo,DRUG: AS012|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,"Sun Pharma Site 15, Phoenix, Arizona, 85018, United States|Sun Pharma Site 02, Bryant, Arkansas, 72022, United States|Sun Pharma Site 09, Fremont, California, 94538, United States|Sun Pharma Site 01, Brandon, Florida, 33511., United States|Sun Pharma Site 06, Fort Lauderdale, Florida, 33308, United States|Sun Pharma Site 04, Miami, Florida, 33175, United States|Sun Pharma Site 05, Miramar, Florida, 33027, United States|Sun Pharma Site 10, Ormond Beach, Florida, 32174, United States|Sun Pharma Site 14, West Lafayette, Indiana, 47906, United States|Sun Pharma Site 12, Baton Rouge, Louisiana, 70809, United States|Sun Pharma Site 13, New Orleans, Louisiana, 70115, United States|Sun Pharma Site 07, Troy, Michigan, 48084, United States|Sun Pharma Site 08, Warwick, Rhode Island, 02886, United States|Sun Pharma Site 03, Dallas, Texas, 75234, United States|Sun Pharma Site 16, Pflugerville, Texas, 78660, United States|Sun Pharma Site 11, Mill Creek, Washington, 98012, United States|Sun Pharma Site 19, Ahmedabad, Gujrat, 380016, India|Sun Pharma Site 20, Gandhinagar, Gujrat, 382428, India|Sun Pharma Site 28, Rajkot, Gujrat, 360005, India|Sun Pharma Site 23, Bangalore, Karnataka, 560074, India|Sun PharmaSite 24, Mysuru, Karnataka, 570001, India|Sun Pharma Site 21, Aurangabad, Maharashtra, 431001, India|Sun Pharma Site 25, Nashik, Maharashtra, 422101, India|Sun Pharma Site 26, Pune, Maharashtra, 411005, India|Sun Pharma Site 17, Rajsamand, Rajasthan,, 313202, India|Sun Pharma Site 27, Lucknow, Uttar Pradesh, 226003, India|Sun Pharma Site 18, Lucknow, Uttar Pradesh, 226005, India|Sun Pharma Site 22, Chandigarh, 160012, India"
NCT02458417,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT02458417,NO,Segmental Vitiligo|Piebaldism,"DEVICE: ReCell|DEVICE: Full surface CO2 laser 200 mJ|DEVICE: Full surface CO2 laser 150 mJ|DEVICE: Fractional CO2 laser 7.5 mJ, 20%",ALL,"ADULT, OLDER_ADULT",PHASE4,"Netherlands Institute for Pigment disorders, Amsterdam, 1105 AZ, Netherlands"
NCT03622320,Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo,https://clinicaltrials.gov/study/NCT03622320,NO,Metabolic Syndrome|Vitiligo,OTHER: Blood sample,ALL,"CHILD, ADULT, OLDER_ADULT",,"Cairo university hospitals, dermatology outpatient clinic, Cairo, Egypt"
NCT04734704,Defining the Role of the Skin Microbiome in Immune-related Adverse Events,https://clinicaltrials.gov/study/NCT04734704,NO,Vitiligo|Skin Melanoma,PROCEDURE: skin swabs at lesional and non-lesional sites|PROCEDURE: skin swabs on skin,ALL,"ADULT, OLDER_ADULT",NA,"Service de Dermatologie - Hôpital Saint-André, Bordeaux, 33075, France"
NCT02506101,"Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo",https://clinicaltrials.gov/study/NCT02506101,YES,Vitiligo|Pigmentation|Dyschromia,DEVICE: narrow-band ultraviolet B phototherapy,ALL,"ADULT, OLDER_ADULT",NA,"Johns Hopkins Dept. of Dermatology, Baltimore, Maryland, 21287, United States"
NCT02660320,"Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin",https://clinicaltrials.gov/study/NCT02660320,NO,Vitiligo - Macular Depigmentation,DEVICE: Dermabrasion|DEVICE: Laser placebo,ALL,"ADULT, OLDER_ADULT",NA,"CHU de Nice, Nice, Alpes-Maritimes, 06200, France|CH Creteil, Paris, Ile De France, France|CHU de Bordeaux, Bordeaux, 33 000, France"
NCT03247400,The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo,https://clinicaltrials.gov/study/NCT03247400,NO,Non-segmental Vitiligo,DRUG: 1% simvastatin-acid sodium salt ointment|DRUG: 1% atorvastatin calcium salt ointment,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,"Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Nicolaus Copernicus University, Faculty of Medicine in Bydgoszcz, Bydgoszcz, Cuiavian-Pomeranian, 85094, Poland"
NCT01640678,Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients,https://clinicaltrials.gov/study/NCT01640678,NO,Piebaldism|Segmental Vitiligo,PROCEDURE: ReCell epidermal cell suspension grafting|PROCEDURE: CO2 laser abrasion + UV-therapy,ALL,"ADULT, OLDER_ADULT",PHASE4,"The Netherlands Institute for pigment disorders, AMC, Amsterdam, 1105 AZ, Netherlands"
NCT01841008,Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control,https://clinicaltrials.gov/study/NCT01841008,NO,Pigmentation Disorders|Vitiligo,DRUG: Protopic|DRUG: Placebo : Diprobase,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,"CHU de Nice - Hôpital de l'Archet, Nice, Alpes-Maritimes, 06200, France|CHU de Bordeaux, Bordeaux, Gironde, 33 404, France"
NCT05554523,How Does Skin Tone Affect Quantitative Photoacoustic Imaging,https://clinicaltrials.gov/study/NCT05554523,NO,Vitiligo|Skin Abnormalities,DEVICE: Photoacoustic imaging,ALL,"ADULT, OLDER_ADULT",,
NCT00484224,Audiological Disturbances in Vitiligo,https://clinicaltrials.gov/study/NCT00484224,NO,Vitiligo|Hearing Loss,,ALL,"CHILD, ADULT",,"Hadassah Medical Organization, Jerusalem, Israel"
NCT05293119,Role of Tofacitinib in Vitiligo Patients,https://clinicaltrials.gov/study/NCT05293119,NO,Vitiligo|Effect of Drug,DRUG: JAK-2 inhibitor|DRUG: Topical corticosteroid,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,
NCT04872257,Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo,https://clinicaltrials.gov/study/NCT04872257,NO,"Vitiligo|Vitiligo, Generalized|Autoimmune|Autoimmune Diseases|Autoimmune Disease Skin",DRUG: Oral Vitamin D|PROCEDURE: NB-UVB Phototherapy|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",NA,"Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", Monterrey, Nuevo Leon, 64460, Mexico"
NCT03270241,Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy,https://clinicaltrials.gov/study/NCT03270241,YES,Vitiligo|Dermatology/Skin - Other,DEVICE: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet,ALL,"ADULT, OLDER_ADULT",NA,"Johns Hopkins Outpatient Center, Baltimore, Maryland, 21287, United States"
NCT06370650,Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study,https://clinicaltrials.gov/study/NCT06370650,NO,Management of Stable Vitiligo,"PROCEDURE: platelet rich plasma, narrow band UVB",ALL,"CHILD, ADULT",NA,"Faculty of Medicine, Sohag University, Sohag, 82515, Egypt"
NCT05364567,Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency,https://clinicaltrials.gov/study/NCT05364567,NO,Vitamin D Deficiency|Vitiligo,DRUG: cholecalciferol (vitamin D3)|PROCEDURE: Phototherapy,ALL,"ADULT, OLDER_ADULT",NA,"Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of"
NCT05316987,Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.,https://clinicaltrials.gov/study/NCT05316987,NO,Active Non Segmental Vitiligo,RADIATION: Narrow band ultraviolet B,ALL,"ADULT, OLDER_ADULT",NA,"Nourhan Emad, Cairo, Helwan, Egypt"
NCT03185312,Cutaneous JAK in Vitiligo and Acne Vulgaris.,https://clinicaltrials.gov/study/NCT03185312,NO,Vitiligo and Acne Vulgaris,DIAGNOSTIC_TEST: skin biopsy,ALL,"CHILD, ADULT, OLDER_ADULT",,
NCT03715829,A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects,https://clinicaltrials.gov/study/NCT03715829,YES,Active Non-segmental Vitiligo,DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: PF-06651600|DRUG: placebo|DRUG: PF06700841|DEVICE: narrow-band UVB phototherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,"Marvel Research, LLC, Huntington Beach, California, 92647, United States|University of California, Irvine, Dermatology Clinical Research Center, Irvine, California, 92697, United States|Vitiligo and Pigmentation Institute Of Southern California, Los Angeles, California, 90036, United States|Dermatology Specialist, Inc., Murrieta, California, 92562, United States|Dermatology Specialists, Inc., Oceanside, California, 92056, United States|UC Davis Health, Sacramento, California, 95816, United States|Brookside Dermatology Associates, Bridgeport, Connecticut, 06606, United States|New England Research Associates, LLC, Bridgeport, Connecticut, 06606, United States|New Horizon Research Center, Miami, Florida, 33165, United States|Park Avenue Dermatology, Orange Park, Florida, 32073, United States|ForCare Clinical Research, Tampa, Florida, 33613, United States|Advanced Skin and MOHS Surgery Center, c/o TrialSpark, Inc., Chicago, Illinois, 60657, United States|Chevy Chase Dermatology Center (TrialSpark, Inc.), Chevy Chase, Maryland, 20815, United States|TrialSpark - Samantha Toerge, MD, Chevy Chase, Maryland, 20815, United States|TrialSpark - Ronald Shore, MD, Rockville, Maryland, 20852, United States|Tobias & Battite, Inc., Boston, Massachusetts, 02111, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|UMass Memorial Medical Center, Hahnemann Campus, Worcester, Massachusetts, 01605, United States|Investigational Drug Service Pharmacy, Worcester, Massachusetts, 01655, United States|UMass Memorial Medical Center Ear Nose and Throat, Worcester, Massachusetts, 01655, United States|University of Massachusetts Medical School, Worcester, Massachusetts, 01655, United States|Henry Ford Hospital Department of Dermatology, Detroit, Michigan, 48202, United States|University of Minnesota Department of Dermatology, Minneapolis, Minnesota, 55455, United States|The Dermatology Group, P.C., Verona, New Jersey, 07044, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10003, United States|Upper West Side Dermatology c/o TrialSpark, Inc, New York, New York, 10023, United States|MDCS: Medical Dermatology & Cosmetic Surgery (TrialSpark, Inc.), New York, New York, 10065, United States|South Nassau Dermatology, Oceanside, New York, 11572, United States|TrialSpark, Inc. - Russell W. Cohen, MD, Oceanside, New York, 11572, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, 28411, United States|Remington-Davis, Inc. Clinical Research, Columbus, Ohio, 43215, United States|ForeFront Dermatology, Columbus, Ohio, 43220, United States|Vital Prospects Clinical Research Institute, PC, Tulsa, Oklahoma, 74136, United States|University Physicians Group, Austin, Texas, 78701, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390-9191, United States|Pickens Academic Tower, Houston, Texas, 77030, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Clinical Research, Inc, Norfolk, Virginia, 23502, United States|Tamjidi Skin Institute (TrialSpark, Inc.), Vienna, Virginia, 22182, United States|The Skin Hospital, Darlinghurst, New South Wales, 2010, Australia|Premier Specialists Pty Ltd, Kogarah, New South Wales, 2217, Australia|Veracity Clinical Research Pty Ltd, Woolloongabba, Queensland, 4102, Australia|Skin Health Institute, Carlton, Victoria, 3053, Australia|Sinclair Dermatology, East Melbourne, Victoria, 3002, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|The Royal Melbourne Hospital, Parkville, Victoria, 3052, Australia|Hôpital Erasme Dermatology, Brussels, 1070, Belgium|UZ Brussel - Dermatology, Brussel, 1090, Belgium|UZ Gent - Dermatology, Gent, 9000, Belgium|Dr. Chih-ho Hong Medical Inc., Surrey, British Columbia, V3R 6A7, Canada|Enverus Medical Research, Surrey, British Columbia, V3V 0C6, Canada|University of British Columbia, Vancouver, British Columbia, V5Z 4E8, Canada|Wiseman Dermatology Research Inc., Winnipeg, Manitoba, R3M 3Z4, Canada|CCA Medical Research, Ajax, Ontario, L1S 7K8, Canada|Guenther Research Inc., London, Ontario, N6A 3H7, Canada|Lynderm Research Inc., Markham, Ontario, L3P 1X3, Canada|DermEdge Research, Mississauga, Ontario, L5H 1G9, Canada|North York Research Inc., North York, Ontario, M2M 4J5, Canada|The Centre for Clinical Trials, Oakville, Ontario, L6J 7W5, Canada|The Centre for Dermatology, Richmond Hill, Ontario, L4B 1A5, Canada|K.Papp Clinical Research, Waterloo, Ontario, N2J 1C4, Canada|Innovaderm Research Inc., Montreal, Quebec, H2X 2V1, Canada|Diex Research Sherbrooke Inc., Sherbrooke, Quebec, J1L 0H8, Canada|Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Quebec, G1V 4X7, Canada|Centre de Recherche Saint-Louis, Quebec, G1W 4R4, Canada|Centre de Recherche Saint-Louis, Quebec, G1W1S2, Canada|Fachklinik Bad Bentheim, Fachbereich Dermatologie und Allergologie, Dermatologische Ambulanz, Bad Bentheim, 48455, Germany|Universitaetsklinikum Erlangen Hautklinik Studienambulanz, Erlangen, 91054, Germany|Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt am Main, 60590, Germany|Universitaetsklinikum Schleswig-Holstein, Campus Luebeck CCIM, Luebeck, 23538, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz, 55131, Germany|Universitaetsklinikum Muenster, Muenster, 48149, Germany|Istituti Fisioterapici Ospitalieri, Istituto di Ricovero e Cura a Carattere Scientifico,, Roma, RM, 00144, Italy|Nagoya City University Hospital - Dermatology, Nagoya, Aichi, 467-8602, Japan|Tohoku University Hospital, Sendai, Miyagi, 980-8574, Japan|Nippon Medical School Hospital, Bunkyo-ku, Tokyo, 113-8603, Japan|Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023, Japan|Yamanashi Prefectural Central Hospital, Kofu, Yamanashi, 400-8506, Japan|Dongguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, 10326, Korea, Republic of|The Catholic University of Korea, St. Vincent's Hospital, Suwon-si, Gyeonggi-do, 16247, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, 16499, Korea, Republic of|Inha University Hospital, Incheon, 22332, Korea, Republic of|Severance Hospital, Yonsei University Health System, Seoul, 03722, Korea, Republic of|Hospital de la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Universitario Reina Sofia, Cordoba, 14004, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 83301, Taiwan|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan"
NCT05536856,Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT05536856,NO,Vitiligo|Topical Fluorouracil|Effervescent Mixture,DRUG: a new effervescent mixture 5-florouracil formula|DRUG: 5-Fluorouracil plain powder,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,"Facualty of Pharmacy, Al Azhar University, Cairo, 11765, Egypt"
NCT05750823,A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo,https://clinicaltrials.gov/study/NCT05750823,NO,Nonsegmental Vitiligo With Genital Involvement,DRUG: Ruxolitinib Cream,ALL,"ADULT, OLDER_ADULT",PHASE2,"Center For Dermatology Clinical Research, Inc, Fremont, California, 94538, United States|Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, 90036, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059-3526, United States|Apex Clinical Research Center, Mayfield, Ohio, 44124, United States|Austin Institute For Clinical Research Aicr Pflugerville, Pflugerville, Texas, 78660, United States|Innovative Dermatology: Legacy Medical Village, Plano, Texas, 75024-4319, United States|Dermatology Research Institute, Calgary, Alberta, T2J 7E1, Canada|Simcomed Health Ltd, Barrie, Ontario, L4M 7G1, Canada|Skin Centre For Dermatology, Peterborough, Ontario, K9J 5K2, Canada|Research Toronto, Toronto, Ontario, M3H 5Y8, Canada|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, 33075, France|Hopital Henri Mondor Service de Dermatologie, Creteil, 94000, France|Chu Nice Hopital Archet 2, Nice, 06202, France"
NCT03365141,Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo,https://clinicaltrials.gov/study/NCT03365141,NO,Vitiligo|Treatment|Intralesional Injection|Corticosteroid,DRUG: Triamcinolone acetonide 0.4mg/cc|DEVICE: Phototherapy (NBUVB or excimer laser)|DRUG: Topical tacrolimus,ALL,"ADULT, OLDER_ADULT",NA,"St. Vincent's Hospital, Suwon, Gyonggi-do, 16247, Korea, Republic of"
NCT02038257,Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP,https://clinicaltrials.gov/study/NCT02038257,NO,Vitiligo|Depigmented Scars|Depigmentation,PROCEDURE: MKTP (melanocyte keratinocyte transplant procedure)|DEVICE: Collagen Dressing|DEVICE: Vaseline Impregnated Gauze|DEVICE: Carbon Dioxide Laser|DEVICE: Dermabrasion,ALL,"ADULT, OLDER_ADULT",NA,"Henry Ford Dermatology, Detroit, Michigan, 48202, United States"
